[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN112813082A - Gene for expressing telomerase, recombinant plasmid, recombinant cell and application - Google Patents

Gene for expressing telomerase, recombinant plasmid, recombinant cell and application Download PDF

Info

Publication number
CN112813082A
CN112813082A CN202011599625.6A CN202011599625A CN112813082A CN 112813082 A CN112813082 A CN 112813082A CN 202011599625 A CN202011599625 A CN 202011599625A CN 112813082 A CN112813082 A CN 112813082A
Authority
CN
China
Prior art keywords
leu
lys
telomerase
ser
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011599625.6A
Other languages
Chinese (zh)
Inventor
奚绪光
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
French National Research Centre
Northwest A&F University
Centre National de la Recherche Scientifique CNRS
Original Assignee
French National Research Centre
Northwest A&F University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by French National Research Centre, Northwest A&F University filed Critical French National Research Centre
Priority to CN202011599625.6A priority Critical patent/CN112813082A/en
Publication of CN112813082A publication Critical patent/CN112813082A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1276RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07049RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention provides a gene for expressing telomerase, a recombinant plasmid, a recombinant cell and application, belonging to the technical field of genetic engineering; the genes include a first gene or a second gene, the first gene expressing a first telomerase; the second gene expresses a second telomerase; the amino acid sequence of the first telomerase is shown in SEQ ID NO. 1; the amino acid sequence of the second telomerase is shown in SEQ ID NO. 2. The first telomerase is derived from Candida tropicalis (Candida tropicalis); the second telomerase is derived from candida albicans (candida albicans). The gene for expressing the telomerase can be expressed in a large amount in escherichia coli, saccharomycetes and Sf9 cells, and the expressed telomerase has biological activity.

Description

Gene for expressing telomerase, recombinant plasmid, recombinant cell and application
Technical Field
The invention relates to the technical field of genetic engineering, in particular to a gene for expressing telomerase, a recombinant plasmid, a recombinant cell and application.
Background
Telomeres are small DNA-protein complexes present at the end of the linear chromosomes of eukaryotic cells and serve to maintain chromosomal integrity and control the cell division cycle. The length of telomeres reflects the history and replication potential of the cell. Telomeres have important functions of maintaining chromosome stability and cell activity in cells of different species, and telomerase can prolong shortened telomeres (the shortened telomeres are limited in cell replication capacity), so that the proliferation capacity of cells in vitro is enhanced. Telomerase has important effects in keeping telomere stable, complete genome, long-term activity of cells, potential continued proliferation capacity and the like. The prior art discloses a technical scheme for expressing yeast telomerase in yeast, but the process of obtaining the yeast telomerase by the method has the technical problem of low yield.
Disclosure of Invention
The invention aims to provide a gene for expressing telomerase, a recombinant plasmid, a recombinant cell and application.
In order to achieve the above object, the present invention provides the following technical solutions:
the invention provides a gene for expressing telomerase, wherein the gene comprises a first gene or a second gene, and the first gene expresses a first telomerase; the second gene expresses a second telomerase; the amino acid sequence of the first telomerase is shown in SEQ ID NO. 1; the amino acid sequence of the second telomerase is shown in SEQ ID NO. 2.
Preferably, the nucleotide sequence of the first gene is shown as SEQ ID NO. 3; the nucleotide sequence of the second gene is shown as SEQ ID NO. 4.
The invention provides a recombinant plasmid containing the gene of the scheme.
Preferably, the backbone plasmid for construction of the recombinant plasmid includes pET15b-s μmo, pPICZA, pPICZaA or pTrix.
The invention provides a recombinant cell comprising the recombinant plasmid of the scheme.
Preferably, when the skeleton plasmid for constructing the recombinant plasmid is pET15b-s mu mo, the original cells of the recombinant cells comprise Escherichia coli; when the skeleton plasmid for constructing the recombinant plasmid is pPICZA or pPICZaA, the primary cell of the recombinant cell comprises yeast; when the backbone plasmid for construction of the recombinant plasmid is pTrix, the original cells of the recombinant cells include Sf9 cells.
The invention provides application of the gene or the recombinant plasmid or the recombinant cell in the scheme in preparing telomerase.
Preferably, when the original cell of the recombinant cell is Escherichia coli, the application comprises the following steps:
1) sequentially carrying out activation culture and amplification culture on the recombinant cells to obtain a bacterial liquid; OD of the bacterial liquid600The value is 0.5 to 0.7; the culture mediums of the activation culture and the amplification culture respectively comprise LB liquid culture mediums containing ampicillin; the concentration of the ampicillin in the LB liquid culture medium is 80-120 mug/mL;
2) adding isopropyl thiogalactoside into the bacterial liquid until the molar concentration of the isopropyl thiogalactoside is 0.2-0.4 mM, and inducing telomerase to express for 12-18 h under the conditions of 100-200 rpm and 15-20 ℃ to obtain an inducing liquid;
3) centrifuging the inducing solution, and collecting the precipitate; dissolving the precipitate by using an imidazole aqueous solution to obtain a dissolved solution; the ratio of the volume of the imidazole aqueous solution to the mass of the precipitate is 8-12 mL: 1g of a compound;
4) crushing the dissolved solution under high pressure under the condition of 800-1200 bar, and then performing ultrasonic crushing under the condition of 300-500W to obtain a crushed solution;
5) centrifuging the crushed solution for 30-50 min at 10000-15000 rpm, collecting supernatant, filtering the supernatant by using a 0.45-micrometer filter head, and collecting first filtrate; and (3) loading the first filtrate to an NI chromatographic column, eluting effluent liquid by eluent, and collecting components corresponding to a third peak to obtain a crude extract containing telomerase.
Preferably, the high-pressure crushing time in the step 4) is 3-5 times, and the interval time between two adjacent high-pressure crushing times is 2-5 min; the ultrasonic crushing times are 2-4 times, the ultrasonic treatment time is 6-8 seconds, the interval is 2-4 seconds, and the ultrasonic treatment time is 2-4 min each time.
Preferably, the loading speed in the step 5) is 1 ml/min; the elution rate was 2 ml/min.
Preferably, after the crude extract is obtained in step 5), the purification of the crude extract is further included, and the purification method comprises the following steps:
6) mixing the crude extract with s mu mo enzyme, carrying out s mu mo enzyme digestion to obtain a first protein, adjusting the salt concentration of the first protein to 280mM, filtering by using a 0.45 mu m filter head, and collecting a second filtrate;
7) loading the second filtrate into an SP chromatographic column, eluting effluent liquid of eluent, collecting components corresponding to an elution peak, and performing SDS-PAGE electrophoresis, wherein the protein with the size of 100KD is a second protein;
8) reversely hanging the second protein by passing through an anti-EDTANI column at the speed of 1mL/min, and carrying out first concentration by adopting a 30KD concentration tube at the temperature of 1-5 ℃ and at the speed of 3000-4000 rpm until the volume after concentration is 0.5-1 mL to obtain a first concentrated solution;
9) loading the first concentrated solution to an S200 chromatographic column, eluting effluent liquid of eluent, collecting components corresponding to an elution peak, and performing SDS-PAGE electrophoresis, wherein the protein with the size of 100KD is a third protein;
10) and secondly concentrating the third protein by adopting a 30KD concentration tube at 1-5 ℃ and 3000-4000 rpm until the volume of the concentrated third protein is 0.5-1 mL, thus obtaining the purified telomerase.
The invention has the beneficial effects that: the invention provides a gene for expressing telomerase, wherein the gene comprises a first gene or a second gene, and the first gene expresses a first telomerase; the second gene expresses a second telomerase; the amino acid sequence of the first telomerase is shown in SEQ ID NO. 1; the amino acid sequence of the second telomerase is shown in SEQ ID NO. 2. The first telomerase is derived from Candida tropicalis (Candida tropicalis); the second telomerase is derived from candida albicans (candida albicans). The gene for expressing the telomerase can be expressed in a large amount in escherichia coli, saccharomycetes and Sf9 cells, and the expressed telomerase has biological activity.
Drawings
FIG. 1 shows the results of the crude purification by Ni column in example 2;
FIG. 2 shows the results of purification of SP column in example 2;
FIG. 3 shows the purification result of the S200 column in example 2;
FIG. 4 shows the concentration result of the purified protein on the S200 column in example 2;
FIG. 5 is the telomerase activity assay of example 3;
FIG. 6 is a diagram showing the results of electrophoresis of pPICZA vector in example 6;
FIG. 7 is a graph showing the results of electrophoresis of the pPICZaA vector of example 6;
FIG. 8 shows the results of NI column purification in example 6;
FIG. 9 shows the results of purification of SP column in example 6;
FIG. 10 shows the purification result of S200 in example 6;
FIG. 11 shows the concentration results in example 6;
FIG. 12 shows the results of the activity assay in example 6;
FIG. 13 shows the results of NI column purification in example 8;
FIG. 14 shows the results of purification of SP column in example 8;
FIG. 15 shows the purification result of S200 in example 8;
FIG. 16 shows the concentration results in example 8;
FIG. 17 shows the results of activity measurement in example 8.
Detailed Description
The invention provides a gene for expressing telomerase, wherein the gene comprises a first gene or a second gene, and the first gene expresses a first telomerase; the second gene expresses a second telomerase; the amino acid sequence of the first telomerase is shown in SEQ ID NO. 1; the amino acid sequence of the second telomerase is shown in SEQ ID NO. 2.
In the invention, the nucleotide sequence of the first gene is shown as SEQ ID NO. 3; the nucleotide sequence of the second gene is shown as SEQ ID NO. 4.
The first telomerase is derived from Candida tropicalis (Candida tropicalis); the second telomerase is derived from candida albicans (candida albicans). The gene for expressing the telomerase can be expressed in a large amount in escherichia coli, and the expressed telomerase has biological activity.
The invention provides a recombinant plasmid containing the gene of the scheme.
In the present invention, the backbone plasmid for construction of the recombinant plasmid preferably includes pET15 b-s. mu. mo, pPICZA, pPICZaA or pTrix.
In the present invention, when the backbone plasmid for construction of the recombinant plasmid is pET15b-s μmo, the gene is preferably inserted between EcoR I and XhoI cleavage sites of pET15b-s μmo; when the gene is the first gene, the nucleotide sequence of the recombinant plasmid is shown as SEQ ID NO. 5; when the gene is the second gene, the nucleotide sequence of the recombinant plasmid is shown as SEQ ID NO. 6.
In the present invention, when the backbone plasmid for construction of the recombinant plasmid is pPICZA or pPICZaA, the gene is preferably inserted between NdeI and SalI cleavage sites of pPICZA or pPICZaA.
In the present invention, when the backbone plasmid for construction of the recombinant plasmid is pTrix, the gene is preferably inserted between NdeI and SalI cleavage sites of pTrix. The construction method of the recombinant plasmid is not particularly limited in the invention, and the conventional method in the field can be adopted.
The invention provides a recombinant cell comprising the recombinant plasmid of the scheme.
In the present invention, when the backbone plasmid for construction of the recombinant plasmid was pET15b-s μmo, the original cells of the recombinant cells included E.coli; when the skeleton plasmid for constructing the recombinant plasmid is pPICZA or pPICZaA, the primary cell of the recombinant cell comprises yeast; when the backbone plasmid for construction of the recombinant plasmid is pTrix, the original cells of the recombinant cells include Sf9 cells. The method for constructing the recombinant cell is not particularly limited, and a conventional method in the art can be adopted.
The invention provides application of the gene or the recombinant plasmid or the recombinant cell in the scheme in preparing telomerase.
In the present invention, when the original cell of the recombinant cell is Escherichia coli, the application comprises the steps of:
1) sequentially carrying out activation culture and amplification culture on the recombinant cells to obtain a bacterial liquid; OD of the bacterial liquid600The value is 0.5 to 0.7; the culture mediums of the activation culture and the amplification culture respectively comprise LB liquid culture mediums containing ampicillin; the concentration of the ampicillin in the LB liquid culture medium is 80-120 mug/mL;
2) adding isopropyl thiogalactoside into the bacterial liquid until the molar concentration of the isopropyl thiogalactoside is 0.2-0.4 mM, and inducing telomerase to express for 12-18 h under the conditions of 100-200 rpm and 15-20 ℃ to obtain an inducing liquid;
3) centrifuging the inducing solution, and collecting the precipitate; dissolving the precipitate by using an imidazole aqueous solution to obtain a dissolved solution; the ratio of the volume of the imidazole aqueous solution to the mass of the precipitate is 8-12 mL: 1g of a compound;
4) crushing the dissolved solution under high pressure under the condition of 800-1200 bar, and then performing ultrasonic crushing under the condition of 300-500W to obtain a crushed solution;
5) centrifuging the crushed solution for 30-50 min at 10000-15000 rpm, collecting supernatant, filtering the supernatant by using a 0.45-micrometer filter head, and collecting first filtrate; and (3) loading the first filtrate to an NI chromatographic column, eluting effluent liquid by eluent, and collecting components corresponding to a third peak to obtain a crude extract containing telomerase.
Preferably, the high-pressure crushing time in the step 4) is 3-5 times, and the interval time between two adjacent high-pressure crushing times is 2-5 min; the ultrasonic crushing is carried out for 2-4 times, the ultrasonic treatment is carried out for 6-8 s at intervals of 2-4 s, and the time of each ultrasonic treatment is 2-4 min.
Preferably, the loading speed in the step 5) is 1 ml/min; the elution rate was 2 ml/min.
Preferably, after the crude extract is obtained in step 5), the purification of the crude extract is further included, and the purification method comprises the following steps:
6) mixing the crude extract with s mu mo enzyme, carrying out s mu mo enzyme digestion to obtain a first protein, adjusting the salt concentration of the first protein to 280mM, filtering by using a 0.45 mu m filter head, and collecting a second filtrate;
7) loading the second filtrate into an SP chromatographic column, eluting effluent liquid of eluent, collecting components corresponding to an elution peak, and performing SDS-PAGE electrophoresis, wherein the protein with the size of 100KD is a second protein;
8) reversely hanging the second protein by passing through an anti-EDTANI column at the speed of 1mL/min, and carrying out first concentration by adopting a 30KD concentration tube at the temperature of 1-5 ℃ and at the speed of 3000-4000 rpm until the volume after concentration is 0.5-1 mL to obtain a first concentrated solution;
9) loading the first concentrated solution to an S200 chromatographic column, eluting effluent liquid of eluent, collecting components corresponding to an elution peak, and performing SDS-PAGE electrophoresis, wherein the protein with the size of 100KD is a third protein;
10) and secondly concentrating the third protein by adopting a 30KD concentration tube at 1-5 ℃ and 3000-4000 rpm until the volume of the concentrated third protein is 0.5-1 mL, thus obtaining the purified telomerase.
According to the invention, firstly, a recombinant cell is required to be constructed, and after the recombinant cell is obtained, the recombinant cell is subjected to activation culture and expansion culture in sequence to obtain a bacterial liquid. In the invention, the temperature of the activation culture and the temperature of the amplification culture are respectively preferably 37 ℃, the rotating speed is respectively preferably 150-200 rpm, and more preferably 180 rpm; the activation culture time is preferably 5-8 h, and more preferably 6 h; the time of the amplification culture is determined by the OD of the bacterial liquid600The value is 0.5-0.7, preferably 0.6; the culture mediums of the activation culture and the amplification culture respectively comprise LB liquid culture mediums containing ampicillin (Amp); the concentration of the ampicillin in the LB liquid culture medium is preferably 80-120 mu g/mL, and more preferably 100 mu g/mL.
After obtaining a bacterial liquid, adding isopropyl thiogalactoside (IPTG) into the bacterial liquid until the molar concentration of the isopropyl thiogalactoside is 0.2-0.4 mM, preferably 0.3mM, and inducing telomerase to express for 12-18 h under the conditions of 100-200 rpm and 15-20 ℃ to obtain an inducing liquid; the induction speed is preferably 150rpm, the temperature is preferably 18 ℃, and the time is preferably 15 h.
After obtaining the inducing liquid, centrifuging the inducing liquid, and collecting the precipitate; dissolving the precipitate by using an imidazole aqueous solution to obtain a dissolved solution; the ratio of the volume of the imidazole aqueous solution to the mass of the precipitate is 8-12 mL: 1g, preferably 10 mL: 1g of a compound; in the invention, the rotation speed of the centrifugation is preferably 4000-5000 rpm, preferably 4500rpm, and the temperature is preferably 18 ℃. In the present invention, the formulation of the aqueous imidazole solution is preferably: 500mM NaCl, 20mM Tris-HCl, pH 7.5, 10% glycerol, 5mM imidazole.
After a dissolving solution is obtained, crushing the dissolving solution at 800-1200 bar, preferably at 1000bar under high pressure, and then performing ultrasonic crushing at 300-500W, preferably at 400W to obtain a crushing solution; the high-pressure crushing frequency is preferably 3-5 (the escherichia coli can crack all cells after 3-5 times of high-pressure crushing, and the cells become clear after crushing compared with the cells before crushing), and more preferably 4 times; the interval time between two adjacent high-pressure crushing is preferably 2-5 min; the number of times of ultrasonic crushing is preferably 2-4, more preferably 3, ultrasonic treatment is carried out for 6-8 s at intervals of 2-4 s, and the time of each ultrasonic treatment is preferably 2-4 min, more preferably 3 min.
After obtaining the crushing liquid, centrifuging the crushing liquid for 30-50 min, preferably 40min, at 10000-15000 rpm, preferably 12000rpm, collecting the supernatant, filtering the supernatant by using a 0.45-micron filter membrane, and collecting a first filtrate; adding the first filtrate into an NI chromatographic column, eluting effluent liquid by eluent, and collecting components corresponding to a third peak to obtain a crude extract containing telomerase, wherein the step is used for carrying out crude purification on target protein; in the present invention, the loading speed is preferably 1 ml/min; the NI chromatography column preferably has a size of 5 mL.
In the specific implementation process of the invention, after the first filtrate is loaded to the NI chromatographic column, 50ml of 5mM imidazole binding buffer (imidazole binding solution: formulation: 500mM NaCl, 20mM Tris-HCl, pH 7.5, 10% glycerol, 5mM imidazole), 20-fold volume of 30mM imidazole Washbuffer (imidazole Elution solution), and 5% to 80% B (B: 500mM imidazole Elution buffer) are sequentially added, wherein the formulation is 500mM NaCl, 20mM HCl, pH 7.5, 10% glycerol, 500mM imidazole) are delayed by 20-fold volume (100ml), the Elution speed is preferably 2ml/min, and 1.8ml/tube receives each collection component.
After the crude extract is obtained, the method adopts the s mu mo enzyme to be mixed with the crude extract for s mu mo enzyme digestion to obtain a first protein, the salt concentration of the first protein is adjusted to 280mM, a 0.45 mu m filter head is adopted for filtering, and a second filtrate is collected, wherein the step is used for cutting off a label at the front end of a target protein; the reagent used to adjust the salt concentration of the first protein to 280mM is preferably 60ml of a reduced salt buffer.
In the invention, the s μmo enzyme digestion system is as follows: according to the following steps: mu. mo enzyme was added at a mass ratio of 100(suom enzyme: target protein), and the cleavage was performed overnight at 4 ℃.
In the present invention, the salt-reducing buffer preferably comprises the following components: 50mM NaCl, 20mM Tris-HCl, pH 7.5, 10% glycerol, 2mM EDTA and 1mM DTT.
After the second filtrate is obtained, the second filtrate is loaded to an SP chromatographic column, the effluent liquid of eluent elution is collected, the components corresponding to the elution peak are collected and subjected to SDS-PAGE electrophoresis, the protein with the size of 100KD is the second protein, and the step has the effects of improving the protein purity and removing part of impure proteins.
In the present invention, the procedure of the SDS-PAGE electrophoresis is preferably: 80V, 20 min; 130V and 1 h. A15. mu.L sample was taken for electrophoresis.
In the specific implementation process of the invention, the loading speed is preferably 1 ml/min; the flow rate of the elution is preferably 2ml/min, 1.8ml/tube receiving; elution was performed with 10% (volume percent) B biningbuffer for 10 column volumes at a flow rate of 2mL/min, followed by a delay of 100mL for 15% B to 60% B.
After the second protein is obtained, the second protein is reversely hung on the EDTANI column at the speed of 1mL/min, a 30KD concentration tube is adopted, the first concentration is carried out under the conditions of 1-5 ℃ and 3000-4000 rpm until the volume after concentration is 0.5-1 mL, and a first concentrated solution is obtained, wherein the step has the effect of removing the protein which is not cut through the reverse hanging, and the preparation is carried out for the next step of passing through a molecular sieve after concentration; the temperature of the first concentration is preferably 4 ℃ and the rotation speed is preferably 3500 rpm.
After the first concentrated solution is obtained, loading the first concentrated solution to an S200 chromatographic column, eluting effluent liquid by eluent, collecting components corresponding to an elution peak, performing SDS-PAGE electrophoresis, taking the protein with the size of 100KD as a third protein, further improving the protein purity by a molecular sieve, and simultaneously obtaining uniform protein; the loading rate is preferably 0.6ml/min, 1ml/tube receiving.
After the third protein is obtained, carrying out second concentration on the third protein by adopting a 30KD concentration tube at the temperature of 1-5 ℃ and under the condition of 3000-4000 rpm until the volume of the concentrated third protein is 0.5-1 mL, thus obtaining purified telomerase; the temperature of the second concentration is preferably 4 ℃ and the rotation speed is preferably 3500 rpm.
After obtaining the purified telomerase, the invention also comprises the step of performing cryopreservation on the purified telomerase; the temperature of the cryopreservation is preferably-80 ℃.
The technical solution of the present invention will be clearly and completely described below with reference to the embodiments of the present invention. It is to be understood that the described embodiments are merely exemplary of the invention, and not restrictive of the full scope of the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
In the invention, the process steps of recombinant cell construction for expressing two kinds of telomerase, telomerase purification and the like are the same.
Example 1
PCR amplification of the sequence of interest:
50 μ l system:
Figure BDA0002868535380000061
the primers (primer (F/R)) used therein were as follows:
Trop-F:
tagGAATTCCATATGCAGACCATCTCTCTGCTGCAGTACGTT,SEQ ID NO.7;
Trop-R:tcgctcgagttagtcgacGATGGTCAGGGTGTACAGCCATTCGA,SEQ ID NO.8;
CN F:taggaattccatatgaccgtgaaagtgaacgaaaagaaaaccctgctgcagta,SEQ ID NO.9;
CN R:tcgctcgagttagtcgactatattcaatgtttgtacccactcgactatttc,SEQ ID NO.10。
and (3) PCR circulation: at 98 ℃ for 10 s; at 62 deg.C, 10s, 72 deg.C, 2min30s, 72 deg.C, 7min, 30 cycles; 16 ℃ and infinity;
after the amplification, electrophoresis detection is carried out, 1% agarose, 90V, 50min, 50. mu.l of sample and 5. mu.l of 10x loading are carried out, then gel cutting recovery is carried out, and after recovery, enzyme digestion is carried out by using EcoR I and XhoI.
10. mu.l of digestion system:
Figure BDA0002868535380000071
after enzyme digestion, putting the mixture into a 65 ℃ oven for inactivation for 20min, then connecting the template with a pET-15b-s mu mo carrier,
ligation system 10. mu.l:
Figure BDA0002868535380000072
ligation was carried out in a 15 ℃ water bath for 3h, after which 10. mu.l of the ligation product was transferred in its entirety to 2984. After colony PCR detection, the quality-improved grains are shaken for enzyme digestion identification. The final plasmids were all correct and transformed into BL 21.
Example 2
1. Activating the recombinant cell strain: selecting a single clone for activation, namely 10mL of LB liquid culture medium +10 mu l of Amp + the recombinant cell (pET-15b-s mu mo-Trop-BL21) prepared in the example 1, wherein the Amp concentration is 100 mu g/mL, and activating for 6 hours at 37 ℃ and 180rpm in a constant temperature shaking table;
2. and (3) amplification culture: antibiotic Amp was added to LB medium to a final concentration of 100. mu.g/mL, at a ratio of 1: adding bacterial liquid in a volume ratio of 500 for amplification culture (1.5L LB/bottle), and performing amplification culture in a constant temperature shaking table at 37 ℃ and 180 rpm;
3. IPTG induction: monitoring OD600 value about 0.6, adding 450 μ l 1M IPTG (isopropyl thiogalactoside) to make its final concentration be 0.3mM, 150rpm, inducing at 18 deg.C for 15h, and inducing expression of target protein;
4. and (3) centrifugal bacterium collection: after centrifugation (18 ℃, 4500rpm), an amount of 11.97g of microbial biomass was recovered, and a 5mM imidazole solution was used as a 1: 10 (mass-to-volume ratio (g/mL), namely the mass of the thalli and the volume ratio of a solution to be added), dissolving the thalli, and carrying out high-pressure crushing for 4 rounds and ultrasonic crushing for 3 rounds (4 rounds under 1000bar, 400W, ultrasonic treatment for 7s, 3s interval, 3min round ultrasonic treatment, and 3 rounds of total ultrasonic treatment); centrifuging at 12000rpm for 40min, filtering with 0.45 μm membrane, and loading;
5. and (3) crude purification by using a Ni column: the filtered supernatant was applied to a 5ml NI pre-packed column at a rate of 1ml/min, and then 50ml of 5mM imidazole binding buffer (imidazole binding solution: formulation: 500mM NaCl, 20mM Tris-HCl, pH 7.5, 10% glycerol, 5mM imidazole), 20-fold volume of 30mM imidazole Washbuffer (imidazole eluting solution), and 5% to 80% B (B: 500mM imidazole Elution buffer) formulation: 500mM NaCl, 20mM Tris-HCl, pH 7.5, 10% glycerol, 500mM imidazole) were delayed by 20-fold volume (100ml), Elution rate was 2ml/min, and 1.8ml/tube were used to collect each collected fraction, and this step was intended to perform crude purification of the target protein. The crude purification result of Ni column is shown in FIG. 1, most of the eluted first two peaks are hetero-proteins, and the third peak (corresponding to 20-45 tubes) is the target protein.
6. S mu mo enzyme is used for removing the tag: the 20 th to 45 th tubes in FIG. 1 were digested with s μmo enzyme. The enzyme digestion system of the s mu mo is as follows: according to the following steps: mu. mo enzyme was added at a mass ratio of 100(suom enzyme: target protein), and the cleavage was performed overnight at 4 ℃.
7. SP column purification: after digestion of 47.5mL of the sample s μmo, 60mL of a salt reducing buffer was added to reduce the salt concentration to 280mM, the solution was filtered through a 0.45 μm filter and applied to an SP column at a rate of 1mL/min, 10 column volumes were eluted at a flow rate of 2mL/min using 10% (volume percent) of B biningbuffer, and then 100mL of elution was delayed by 15% B to 60% B. See figure 2 for the results of SP column purification. The higher peak in the middle of FIG. 2 is the protein of interest (corresponding to tubal proteins 26-46), and the other peaks are the mixture of the protein of interest and the hetero-protein.
8. anti-EDTA NI column purification: collecting the No. 26-46 tube protein shown in figure 2, passing through an anti-EDTANI column at a speed of 1mL/min for reverse hanging, and then concentrating, specifically concentrating with a concentration tube with a pore diameter of 30KD at 4 ℃ and 3500rpm until the volume is 0.5 mL. The purpose of this step is to remove the non-cleaved protein by reverse-hanging, and to prepare it for the next step of molecular sieving after concentration.
9. S200 column purification: the protein sample from step 8 was collected and applied to the S200 column at a rate of 0.6ml/min, and received at 1ml/tube, and the purification results are shown in FIG. 3. The middle peak in FIG. 3 is the target protein (corresponding to tube No. 22-31), and the other peaks include the target protein and the hetero-protein. This step further improves protein purity by molecular sieves while obtaining uniform protein.
10. Concentration: collecting No. 22-31 collected liquid in figure 3, and concentrating, specifically concentrating with a concentration tube with a pore diameter of 30KD at 4 deg.C and 3500rpm until the volume is 0.5 mL. The protein can be frozen after concentration. The final concentration results are shown in FIG. 4.
Example 3
1. Telomerase activity identification reaction solution
40m M Tris-HCl,pH7.8;100m M NaCl;20mM KCl;2mM MgCl2;2mM Mg(AC)2(ii) a 1mM DTT; 0.2mM dNTP; 1 μ M TERT telomerase (purified protein of interest); 1.2. mu.M RNA; 1. mu.M of 5' -FAM-labeled primer (primer sequence: TTAGTGTAAGGA, SEQ ID NO. 11); 2X reaction stop buffer; 1M urea (urea); 0.05% xylene blue;
2. the specific method comprises the following steps:
telomerase primer extension experiments were performed in a 25. mu.L system using 40mM Tris-HCl, pH 7.8, 2mM MgCl2100mM NaCl, 20mM KCl, 1mM DTT, 0.2mM dNTPmix (0.2 mM each of dTTP, dATP, dCTP, dGTP), 2mM Mg (AC)2Sequentially adding 1.0 mu M telomerase, 1.2 mu M RNA and 1 mu M fluorescent primer into a PCR tube, uniformly mixing, carrying out a light-shielding reaction at 37 ℃ for 1h, then adding 10 mu L of 8M urea as loading, adding a reaction termination buffer to terminate the reaction,electrophoresis was performed using 15% urea gel (7M, 19: 1) at 500V for 4h, and after electrophoresis was completed, exposure analysis was performed by a Berlol gel imaging system.
3. The identification result is shown in FIG. 5, wherein M is marker and Trop is the target protein. As can be seen from FIG. 5, the resulting target protein had an elongation activity.
Example 4
The procedure for PCR amplification of the desired sequence was as in example 1.
After the amplification, electrophoresis detection is carried out, 1% agarose, 90V, 50min50 mu l of sample and 5 mu l of 10x loading are carried out, then gel cutting and recovery are carried out, and Nde I and SalI enzyme digestion are carried out after recovery.
10. mu.l of digestion system:
Figure BDA0002868535380000091
inactivating in a 65 ℃ oven for 20min after enzyme digestion, then connecting the template with pPICZA and pPICZaA vectors,
ligation system 10. mu.l:
Figure BDA0002868535380000092
ligation was carried out in a 15 ℃ water bath for 3h, after which 10. mu.l of the ligation product was transferred in its entirety to 2984. After colony PCR detection, the quality-improved grains are shaken for enzyme digestion identification. The final plasmids were all correct.
Example 5
1. And (3) plasmid linearization: the plasmid constructed in example 4 was linearized by SacI single digestion, and run electrophoresis detection at 1% agarose, 100V, 40min 5. mu.l sample + 0.5. mu.l 10 × loading.
2. Alcohol precipitation of linearized plasmid: the plasmid after complete linearization was added with 0.3M sodium acetate (pH5.2) at final concentration and two times the volume of absolute ethanol, and left to stand at-20 ℃ for more than 1 h. Centrifuging at high speed 12000rpm/10min, washing precipitate with 70% ethanol twice, oven drying the precipitate at 65 deg.C, and adding appropriate amount of ddH2O redissolve the DNA pellet (total greater than 5. mu.g).
3. Yeast competence preparation: single colonies of yeast recipient bacteria were picked and inoculated into 5mLYPD medium and shaken overnight at 30 ℃. Inoculating 100mLYPD liquid culture medium with 1% inoculation amount, and shaking overnight at 30 ℃ until OD is 1.3-1.5. Centrifuge at 5000rpm for 5min at 4 deg.C, and discard the supernatant. The cells were resuspended in 40ml of a pretreatment solution (0.1mol/L LiAC, 0.01mol/L DTT, 0.6mol/L sorbitol, 0.01mol/L Tris-HCl7.5), and the cells were left at room temperature for 30min, centrifuged at 4 ℃ at 5000rpm for 10min, and the supernatant was discarded. Then washed 3 times with 5mL of 1mol/L sorbitol, centrifuged at 5000rpm at 4 ℃ for 10min, and the supernatant was discarded. Dissolve in 300. mu.L of 1mol/L ice-cold sorbitol for conversion.
4. Yeast electrotransformation: 80 μ l of competence was mixed with 5-10 μ g of linearized plasmid and transferred to an ice-cold electric rotor. Incubate for 5min on ice. The shock was selected with the appropriate parameters (1500V, 25uF, 200 Ω, 0.2cm cup). 1ml of 1M ice-cold sorbitol was immediately added and transferred to a 15ml tube. Standing and incubating for 1-2 h at 30 ℃, taking 200 mu L of plated YPDs (added with 100ug/ml Zeocin), and slightly centrifuging the rest and then plating YPDS plates. Culturing at 30 ℃. (36h to see the colony)
5. High copy screening: selecting 60-70 monoclonals, and respectively dissolving in 1ml of sterile ddH2And O, mixing uniformly. 0.5 mu L of the culture medium is respectively spotted on 500ug/ml and 1000ug/ml Zeocin YPD plates for culture at 30 ℃, the growth state of the bacteria is observed at intervals, and clones which grow rapidly and can grow on a high-concentration antibiotic plate are selected.
6. Extracting genome DNA: selecting 15-20 clones with faster growth, scraping rice-grain-sized thalli on a flat plate, and suspending the rice-grain-sized thalli in 1ml of ddH2And O, washing and centrifuging to remove the supernatant. 500 μ L sorbitol buffer was resuspended and 50 μ L helicase was added and digested at 37 ℃ for 1-4 h. Mix 1 time every 30 min. 4000rpm, 10min, discard the supernatant and collect the precipitate. 500 μ L Tris Na2EDTA washes 1 time. 500 μ L Tris Na2EDTA heavy suspension, adding 50 u L10% SDS, 65 degrees, 40min, every 10min mixing 1 times. Adding 200 μ L of 5M KAC, mixing, standing on ice for 1 hr, high speed 10min, collecting supernatant, adding equal volume of isopropanol, mixing, and standing at-20 for more than 1 hr. The speed is increased for 10min, the supernatant is discarded, and the precipitate is washed with 80% ice-cold ethanol. Air drying in ddH2And (4) re-dissolving the O.
6. And (3) PCR identification: 5 'AOX, 3' AOX universal primer PCR identification. And selecting a positive recombinant strain.
Example 6
1. Activating the recombinant strain: selecting 6-8 recombinant bacteria prepared in example 5 for monoclonal activation, performing activation on 10mL of BMDY liquid medium + recombinant bacteria (pPICZA-Trop-GS115) in a constant temperature shaking table at 30 ℃ and 180rpm for 24 hours; to OD600The value is 2 to 6.
2. And (3) collecting thalli: centrifuging at 3000rpm for 5-10 min, and collecting thallus;
3. methanol induction: resuspending the cells to OD with BMMY medium containing 0.5% -1% methanol (volume fraction, 99mL of medium added with 1mL of methanol, namely 1%)6001 is ═ 1; the cultivation was continued at 180rpm in a constant temperature shaker at 30 ℃. 1ml of bacterial liquid is collected every 12h, and 0.5-1% of methanol is supplemented every 24 h.
4. And (3) centrifugal bacterium collection: taking 1ml of culture solution every 12h, centrifuging (18 ℃, 4500rpm), collecting the thallus by the pPICZA carrier recombinant bacteria, and collecting the supernatant by the pPICZaA carrier recombinant bacteria.
pPICZA vector recombinant bacteria: the cells were resuspended in 250. mu.Lbindingbuffer. Liquid nitrogen-55 ° -liquid nitrogen (cold-hot-cold cycle 3 times). 60-100 w, performing two ultrasonic cycles (over 3s, stopping for 7s, and total working time of 4min), centrifuging at 12000rpm/min, adding a loading buffer to the supernatant and the precipitate respectively, boiling for 10min, and running glue. (Total protein)
The electrophoresis results are shown in FIG. 6. From the electrophoresis results, it can be seen that the recombinant plasmid successfully expresses the target protein in yeast.
pPICZaA vector recombinant bacteria: the cell fractions were frozen at-20 ℃ for a while, and the supernatant was precipitated by adding 0.43g (1ml) of ammonium sulfate and allowed to stand on ice for 2 hours. At high speed, the supernatant was discarded and the pellet resuspended in 10. mu.L buffer. Dialyzing with 0.25 μm microporous filter membrane, and detecting by running gel. The results of the measurements are shown in FIG. 7.
The pellet was reconstituted with buffer (500mM NaCl, 20mM Tris-HCl, pH 7.5, 10% glycerol) and examined by SDS-PAGE, and the reconstituted supernatant was found to contain the protein of interest, indicating successful expression of the protein of interest in yeast on the recombinant plasmid.
The purification process of the recombinant bacterium telomerase of the pPICZA vector is the same as that of escherichia coli, the specific process refers to the purification steps of the escherichia coli in the example 2, and the following specific purification results are shown: the results of NI column purification are shown in fig. 8. See figure 9 for the results of SP column purification. The purification results of S200 are shown in FIG. 10. The concentration results are shown in FIG. 11. The results of the activity assay are shown in FIG. 12.
Example 7
The procedure for PCR amplification of the desired sequence was as in example 1.
After the amplification, electrophoresis detection is carried out, 1% agarose, 90V, 50min 50. mu.l of sample + 5. mu.l of 10x loading are carried out, then gel cutting and recovery are carried out, and Nde I and Sal I enzyme digestion are carried out after recovery.
10. mu.l of digestion system:
Figure BDA0002868535380000111
after enzyme digestion, putting the mixture into a 65 ℃ oven for inactivation for 20min, then connecting the template with a pTrix vector,
ligation system 10. mu.l:
Figure BDA0002868535380000112
ligation was carried out in a 15 ℃ water bath for 3h, after which 10. mu.l of the ligation product was transferred in its entirety to 2984. After colony PCR detection, the quality-improved grains are shaken for enzyme digestion identification. The final plasmids were all correct.
Example 8
And 5 mu L, Bacmid 2.5.5 mu L of the recombinant plasmid prepared in the embodiment 7 and 100 mu L of sterile water are taken and mixed uniformly, 5 mu L of transfection reagent is added and mixed uniformly, the mixture is placed still for 10 to 30min and then is added into the cultured Sf9 cells uniformly, and the recombinant baculovirus is formed in the host cells through homologous recombination. Cell culture supernatants were collected 3-5 days after transfection as stock solutions for recombinant baculoviruses. Sf9 cells were infected with the virus stock solution, cultured for 3 days, and then the lesion cell culture solution was centrifuged at 4000rpm for 10min to collect cells. The cells were resuspended in 1mL bindingbuffer. And (4) repeatedly freezing and thawing liquid nitrogen. After cell lysis, centrifugation is carried out at 12000rpm for 30min, the supernatant is taken to pass through an NI column, the rest steps are the same as the purification of escherichia coli, and finally protein expression is detected by SDS-PAGE.
The subsequent purification process was the same as that of E.coli, and the specific purification procedure was as in E.coli purification process in example 2. The NI column purification results are shown in fig. 13. See figure 14 for SP column purification results. The purification results of S200 are shown in FIG. 15. The concentration results are shown in FIG. 16. See figure 17 for activity assay results.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.
Sequence listing
<110> northwest agriculture and forestry science and technology university
<120> telomerase expression gene, recombinant plasmid, recombinant cell and application
<160> 11
<170> SIPOSequenceListing 1.0
<210> 1
<211> 881
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 1
Met Gln Thr Ile Ser Leu Leu Gln Tyr Val Lys Asp Asn Ser Ser Asp
1 5 10 15
Gln Ser Val Gln Leu Pro Ser Phe Ile Asn Tyr Leu Lys Ser Val Asn
20 25 30
Leu Ile Glu Ile Thr Lys Pro Asn Lys Leu Pro Arg Ile Thr Ser Asp
35 40 45
Thr Ser Tyr Gln Asp Phe Ile Asn Asn Leu Ile Thr Glu Leu Val Leu
50 55 60
Arg Lys Ser Gln Asn Val Leu Val Ser Gly Tyr Lys Ser Thr Ile Glu
65 70 75 80
Asp Ser Lys Val Ala Leu Pro Cys Val Asn Leu Asp Gly Asn Phe Leu
85 90 95
Pro Thr Asn Leu Asn Asp Ser Asn Trp His Arg Val Phe Thr Leu Leu
100 105 110
Gly Ser Glu Lys Phe Leu Asn Leu Leu Ile Asn His Lys Gly Phe Leu
115 120 125
Lys His Lys Asn Gly Gln Gln Ile Gln Ile Phe Gly Asp Ile Thr Ser
130 135 140
Tyr Ala Lys Pro Ala Ala Lys Ala Val Leu Pro Ile Pro Lys Trp Ile
145 150 155 160
Tyr Lys Phe Asp Val Leu Tyr Gln Ser Arg Asn Pro Arg Tyr Arg Asn
165 170 175
Tyr Glu Ile Ile Arg Thr Asn Val Gln Glu Val Leu Ala Glu Ile Val
180 185 190
Ser Pro Ser Thr Lys Asn Pro Asn Ser Glu Asn Pro Ala Val Lys Lys
195 200 205
Arg Phe Arg Gly Ile Lys Asn Val Val Ser Arg Ile Ile Ser Asn Asp
210 215 220
Lys Lys Cys Arg Tyr Asp Leu Ile Tyr Asn Lys Tyr Leu Ser Ser Ser
225 230 235 240
Asp Thr Arg Lys Leu Lys Thr Met Ile Asp Tyr Ser Thr Lys Phe Asn
245 250 255
Arg Val Val Glu Val Val Leu Ile Ile Met Gly Lys Leu Leu Pro Leu
260 265 270
Asp Ala Trp Gly Gly Thr Glu Asn Lys Lys Val Ile Gln Asp Arg Ile
275 280 285
Val Asp Phe Leu Arg Leu Gly Ala Asn Glu Arg Leu His Leu Asp Asp
290 295 300
Val Leu Ser Gly Ile Lys Leu Ser Lys Phe Lys Trp Leu Gly Val Gly
305 310 315 320
Asn Asn Ile Ser Ser Gln Gln Asp Phe Gln Ile Arg Lys Arg Leu Leu
325 330 335
Glu Gly Tyr Ile Asn Trp Val Phe Ile Ser Leu Val Lys Asn Ile Val
340 345 350
Arg Ala Phe Trp Tyr Val Thr Glu Ser Ser Asn Met Asp Arg Ser Lys
355 360 365
Leu Phe Tyr Phe Thr His Ser Ile Trp Asn Glu Leu Ser Ser Asn Trp
370 375 380
Ile Thr Lys Tyr Ala Lys Gly Asn Leu Val Gln Val Val Ser Pro Glu
385 390 395 400
Ser Lys Gly Gln Phe Thr Asn Gly Lys Ile Lys Leu Ile Pro Lys Arg
405 410 415
Gly Gly Phe Arg Val Ile Cys Val Pro Leu Lys Gln Ser Leu Tyr Ser
420 425 430
Phe Asn Asn Lys Arg Asn Phe Ala Leu Lys Gln Lys Glu Lys Trp Asp
435 440 445
Tyr Ile Phe Tyr Gln Lys Tyr Thr Leu Ser Pro Val Arg Gln Val Leu
450 455 460
Gln Leu Lys Leu Asn Ala Leu Arg Lys Ser Asp Met Gly His Arg Ser
465 470 475 480
Ser Val Asn Ser Thr Asn Glu Val Ala Asp Arg Ile Leu Thr Phe Arg
485 490 495
Asn Asp Leu Leu Lys Lys Asn Lys Thr Leu Pro Val Leu Tyr Met Ile
500 505 510
Lys Phe Asp Met Lys Glu Cys Tyr Asp Arg Leu Asn Gln Asn Ala Leu
515 520 525
Lys Glu Ser Ile Ala Gly Ile Phe Lys Glu Asp Asn Glu Asn Thr Thr
530 535 540
Tyr His Val Arg Glu Tyr Gly Thr Leu Asp Glu Phe Leu Lys Leu Lys
545 550 555 560
Arg Val Arg Thr Leu Ile Glu Thr Glu Val Gln Asn Phe Asn Ile Ile
565 570 575
Met Asn Ser Lys Asp Glu Ala Glu Ala Gly Ser Arg Ser Tyr Gly Thr
580 585 590
Lys Val Asp Lys Val Lys Thr Leu Ser Ile Ser Lys Asn Lys Ile Ile
595 600 605
Glu Val Cys His Ser Gln Ile Glu Asp Ala Thr Cys Leu Val Lys Asn
610 615 620
Lys Glu Gly Gln Tyr Asp Leu Phe Lys Arg Lys Gln Gly Val Phe Gln
625 630 635 640
Gly Phe Ser Leu Ser Gly Ile Phe Cys Asp Ile Leu Tyr Ser Thr Met
645 650 655
Val Ser Lys Glu Phe Lys Phe Leu Trp Glu Ala Thr Glu Asp Asn Leu
660 665 670
Leu Leu Arg Leu Val Asp Asp Phe Ile Phe Ile Thr Ser Asn Lys Asp
675 680 685
Thr Leu Lys Lys Val Lys Asp Lys Ile Ser Ser Asn Glu Leu Gln Lys
690 695 700
Tyr Gly Ala Phe Val Asn His Glu Lys Thr Val Glu Ile Asn Gly Glu
705 710 715 720
Ala Gly Ser Ser Asn Lys Met Thr Phe Val Gly Leu Asp Ile Asn Cys
725 730 735
Leu Thr Leu Asp Val Lys Lys Asp Ser Ser Gln Phe Ser Arg Pro Thr
740 745 750
Cys Lys Phe Arg Ser Phe Lys Ala Leu Phe Ser Asn Leu Lys Gln Phe
755 760 765
Tyr Cys Ser Asn Leu Ser Glu Phe Leu Leu Asp Phe Ser Ser Asn Ser
770 775 780
Leu Glu Thr Ile Arg Glu Asn Val Asp Ala Ile Leu Lys Leu Thr Phe
785 790 795 800
Glu Ala Ile Gln Thr Ser Phe Ala Thr Ile Ser Lys Gln Asp Ser Phe
805 810 815
Glu Arg Tyr Arg Phe Met Lys Phe Leu His Val Ile Ile Glu Thr Thr
820 825 830
Ile Glu Lys Phe Ala Arg Val Asn Gly Ser Met Glu Gly Val Glu Tyr
835 840 845
Leu Leu Thr Cys Ile Lys Ile Thr Ile Thr Lys Ser Leu Ala Phe Met
850 855 860
Ala Thr Lys Gln Glu Ile Ile Glu Trp Leu Tyr Thr Leu Thr Ile Val
865 870 875 880
Asp
<210> 2
<211> 867
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 2
Met Thr Val Lys Val Asn Glu Lys Lys Thr Leu Leu Gln Tyr Val Leu
1 5 10 15
Asp Asn Thr Ser Asn Glu Val Pro Leu Leu Pro Ser Leu Lys Glu Tyr
20 25 30
Met Glu Thr Val Leu Val Tyr Gln Ser Ile Lys Arg Pro Leu Pro Ala
35 40 45
Ile Arg Pro Gln Glu Ser Phe Asp Glu Phe Met Lys Glu Leu Val Thr
50 55 60
Arg Leu Val Met Glu Lys Ser Asn Asn Val Ile Ala Tyr Gly Tyr Lys
65 70 75 80
Thr Ser Ala Met Glu Ser Arg Ser Ile Phe Thr Thr Phe His Ser Ser
85 90 95
Gly Asn Phe Ile Leu Thr His Ile Thr Ser His Asn Trp Ser Thr Ile
100 105 110
Phe Ser Leu Leu Gly Pro Lys Lys Phe Leu Glu Leu Leu Val Asn Asn
115 120 125
Lys Gly Phe Val Ser Lys Val Asn Gly Glu Ser Val Gln Ile Phe Gly
130 135 140
Asp Val Asn Ser His Arg Lys Ala Val Val Val Ser Lys Tyr Ile Thr
145 150 155 160
Lys Phe Asn Val Leu Tyr Asn Ser Tyr Ser Arg Asp Phe Ser Arg Phe
165 170 175
Glu Met Ile Arg Pro Ser Ile Gln Thr Ile Leu Gln Asp Ile Leu Ser
180 185 190
Phe Ser Gly Leu Asn Pro Gly Arg Ser Ser Lys Arg Tyr Arg Gly Phe
195 200 205
Lys Ser Leu Leu Ser Arg Ile Ile Ala Asn Asp Lys Lys Cys Arg Tyr
210 215 220
Asp Ile Leu Tyr Ala Lys Phe Ile Gly Thr Ser Lys Cys Asn Phe Ala
225 230 235 240
Asn Val Val Ser Asn Lys Thr Glu Ile Ser Gln Val Ile Gln Phe Val
245 250 255
Leu Leu Val Leu Gly Lys Leu Leu Pro Leu Asp Ala Trp Gly Gly Val
260 265 270
Ser Asn Lys Lys Ile Ile Lys Asp Arg Val Val Asp Phe Leu Leu Leu
275 280 285
Gly Ala Asn Glu Lys Ile His Met Asp Asp Leu Phe Arg Gly Ile Arg
290 295 300
Leu Lys Asp Phe Lys Trp Leu Gly Arg Ala His Gln Ile Ser Ser Lys
305 310 315 320
Gln Asp Phe Glu Leu Arg Thr Ala Phe Leu Lys Gly Tyr Leu Trp Trp
325 330 335
Leu Phe Glu His Leu Leu Lys Asn Ile Leu Arg Ser Phe Trp Tyr Ile
340 345 350
Thr Glu Thr Ser Ser Ile Val Ser Leu Glu Leu Asn Tyr Phe Pro Gln
355 360 365
Tyr Leu Trp Lys Glu Leu Tyr Glu Ser Trp Val Ser Lys Tyr Ala Lys
370 375 380
Asn Asn Leu Val Lys Met Pro Ser Lys Ile Gln Arg Glu Gln Leu Pro
385 390 395 400
Cys Gly Lys Ile Lys Leu Ile Pro Lys Arg Ser Ser Phe Arg Val Ile
405 410 415
Cys Val Pro Ile Lys Arg Ser Leu Lys Leu Leu Asn Lys Lys Leu Glu
420 425 430
Leu Asp Thr Leu Glu Lys Glu Lys Arg Glu Phe Glu Arg Tyr Arg Lys
435 440 445
Glu Val Leu Ser Pro Val Gly Gln Ile Leu Arg Leu Lys Leu Ser Lys
450 455 460
Leu Arg Asp Thr Tyr Glu Ser Tyr Arg Ala Ser Val His Ser Ser Ser
465 470 475 480
Asp Val Ala Glu Lys Ile Ser Asp Tyr Arg Asp Ser Leu Leu Thr Arg
485 490 495
Phe Gly Glu Ile Pro Lys Leu Phe Ile Leu Lys Phe Asp Met Lys Glu
500 505 510
Cys Tyr Asp Arg Leu Ser Gln Pro Val Leu Met Lys Lys Leu Glu Glu
515 520 525
Leu Phe Glu Asn Gln Asp Asn Lys Thr Ser Tyr Tyr Val Arg Tyr Tyr
530 535 540
Ala Gln Leu Asp Ala Ser His Lys Leu Lys Lys Val Lys Thr Thr Ile
545 550 555 560
Asp Thr Gln Tyr His Asn Leu Asn Ile Leu Ser Ser Ser Arg His Leu
565 570 575
Ser Asn Cys Lys Ser Leu Val Asp Lys Thr Lys Thr Ile Ala Leu Gln
580 585 590
Lys Gly Asn Ile Leu Glu Val Cys Arg Ser Gln Ile Tyr Asp Val Val
595 600 605
Gly Ser Val Lys Asp Ala Arg Gly Asn Leu His Leu Tyr Lys Arg Lys
610 615 620
Arg Gly Val Phe Gln Gly Phe Ser Leu Ser Ser Ile Phe Cys Asp Ile
625 630 635 640
Leu Tyr Ser Ala Met Val His Asp Cys Phe Gln Phe Leu Trp Lys Ser
645 650 655
Lys Gln Asp Phe Leu Phe Val Arg Leu Val Asp Asp Phe Leu Leu Val
660 665 670
Thr Pro Asp Ser Asn Ile Tyr Asp Gln Val His Asn Ile Leu Ser Gly
675 680 685
Lys Ile Leu Glu Ser Tyr Gly Ala Phe Val Asn Lys Asp Lys Thr Val
690 695 700
Val Val Asn Gln Thr Thr Thr Lys Pro Ser Ile Asp Phe Val Gly Leu
705 710 715 720
Glu Val Asn Thr Thr Asp Leu Ser Ile Lys Arg Asn Ser Gly Ser Ile
725 730 735
Ser Leu Val Thr Thr Asn Phe Arg Thr Phe Lys Thr Leu Val Lys Tyr
740 745 750
Leu Lys Thr Phe Tyr Gln Leu Asn Leu Glu Gly Phe Leu Leu Asp Cys
755 760 765
Ser Phe Gly Val Leu Glu Asn Val Leu Glu Asn Met Gly Ser Leu Leu
770 775 780
Arg Leu Val Leu Arg Glu Phe Lys Thr Lys Phe Thr Ser Ile Val Lys
785 790 795 800
Tyr Asp Thr Phe His Cys Tyr Lys Phe Ile Lys Phe Leu Tyr Asp Ile
805 810 815
Ser Asn Tyr Thr Ile Val Lys Tyr Val Glu Thr Asn Ser Asp Trp Asp
820 825 830
Gly Ala Pro Glu Leu Leu Asn Cys Ile Lys Gln Ile Ile Val Lys Glu
835 840 845
Phe Ser Ser Phe Glu Ser Tyr Ser Glu Ile Val Glu Trp Val Gln Thr
850 855 860
Leu Asn Ile
865
<210> 3
<211> 2646
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
atgcagacca tctctctgct gcagtacgtt aaagacaact cttctgacca gtctgttcag 60
ctgccgtctt tcatcaacta cctgaaatct gttaacctga tcgaaatcac caaaccgaac 120
aaactgccgc gtatcacctc tgacacctct taccaggact tcatcaacaa cctgatcacc 180
gaactggttc tgcgtaaatc tcagaacgtt ctggtttctg gttacaaatc taccatcgaa 240
gactctaaag ttgcgctgcc gtgcgttaac ctggacggta acttcctgcc gaccaacctg 300
aacgactcta actggcaccg tgttttcacc ctgctgggtt ctgagaagtt cctgaacctg 360
ctgatcaacc acaaaggttt cctgaaacac aagaatggtc agcagatcca gatcttcggt 420
gacatcacct cttacgcgaa accggcggcg aaagcggttc tgccgatccc gaaatggatc 480
tacaaattcg acgttctgta ccagtctcgt aacccgcgtt accgtaacta cgaaatcatc 540
cgtaccaacg ttcaggaagt tctggcggaa atcgtttctc cgtctaccaa gaatccgaac 600
tctgaaaacc cggcggttaa gaagcgtttc cgtggtatca agaatgttgt ttctcgtatc 660
atctctaacg acaagaagtg ccgttacgac ctgatctaca acaaatacct gtcttcttct 720
gacacccgta aactgaaaac catgatcgac tactctacca aattcaaccg tgttgttgaa 780
gttgttctga tcatcatggg taaactgctg ccgctggacg cgtggggtgg taccgaaaac 840
aagaaggtta tccaggaccg tatcgttgac ttcctgcgtc tgggtgcgaa cgaacgtctg 900
cacctggacg acgttctgtc tggtatcaaa ctgtctaaat tcaaatggct gggtgttggt 960
aacaacatct cttctcagca ggacttccag atccgtaaac gtctgctgga aggttacatc 1020
aactgggttt tcatctctct ggttaagaat atcgttcgtg cgttctggta cgttaccgaa 1080
tcttctaaca tggaccgttc taaactgttc tacttcaccc actctatctg gaacgaactg 1140
tcttctaact ggatcaccaa atacgcgaaa ggtaacctgg ttcaggttgt ttctccggaa 1200
tctaaaggtc agttcaccaa cggtaaaatc aaactgatcc cgaaacgtgg tggtttccgt 1260
gttatctgcg ttccgctgaa acagtctctg tactctttca acaacaaacg taacttcgcg 1320
ctgaaacaga aagagaagtg ggactacatc ttctaccaga aatacaccct gtctccggtt 1380
cgtcaggttc tgcagctgaa actgaacgcg ctgcgtaaat ctgacatggg tcaccgttct 1440
tctgttaact ctaccaacga agttgcggac cgtatcctga ccttccgtaa cgacctgctg 1500
aagaagaaca aaaccctgcc ggttctgtac atgatcaaat tcgacatgaa agaatgctac 1560
gaccgtctga accagaacgc gctgaaagaa tctatcgcgg gtatcttcaa agaagacaac 1620
gaaaacacca cctaccacgt tcgtgaatac ggtaccctgg acgaatttct gaaactgaaa 1680
cgtgttcgta ccctgatcga aaccgaagtt cagaacttca acatcatcat gaactctaaa 1740
gacgaagcgg aagcgggttc tcgttcttac ggtaccaaag ttgacaaagt taaaaccctg 1800
tctatctcta agaataaaat catcgaagtt tgccactctc agatcgaaga cgcgacctgc 1860
ctggttaaga ataaagaagg tcagtacgac ctgttcaaac gtaaacaggg tgttttccag 1920
ggtttctctc tgtctggtat cttctgcgac atcctgtact ctaccatggt ttctaaagaa 1980
tttaaattcc tgtgggaagc gaccgaagac aacctgctgc tgcgtctggt tgacgacttc 2040
atcttcatca cctctaacaa agacaccctg aagaaggtta aagacaaaat ctcttctaac 2100
gaactgcaga aatacggtgc gttcgttaac cacgagaaga ccgttgaaat caacggtgaa 2160
gcgggttctt ctaacaaaat gaccttcgtt ggtctggaca tcaactgcct gaccctggac 2220
gttaagaagg actcttctca gttctctcgt ccgacctgca aattccgttc tttcaaagcg 2280
ctgttctcta acctgaaaca gttctactgc tctaacctgt ctgaatttct gctggacttc 2340
tcttctaact ctctggaaac catccgtgaa aacgttgacg cgatcctgaa actgaccttc 2400
gaagcgatcc agacctcttt cgcgaccatc tctaaacagg actctttcga acgttaccgt 2460
ttcatgaaat tcctgcacgt tatcatcgaa accaccatcg agaagttcgc gcgtgttaac 2520
ggttctatgg aaggtgttga atacctgctg acctgcatca aaatcaccat caccaaatct 2580
ctggcgttca tggcgaccaa acaggaaatc atcgaatggc tgtacaccct gaccatcgtc 2640
gactaa 2646
<210> 4
<211> 2604
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
atgaccgtga aagtgaacga aaagaaaacc ctgctgcagt atgtgctgga taacaccagc 60
aacgaagtgc cgctgctgcc gagcctgaaa gaatatatgg aaaccgtgct ggtgtataaa 120
agcattaaac gcccgctgcc ggcgattcgc ccgcaggaaa gctttgatga atttatgaaa 180
gaactggtga cccgcctggt gatggaaaag agcaacaacg tgattgcgta tggctataaa 240
accagcgcga tggaaagccg cagcattttt accacctttc atagcagcgg caactttatt 300
ctgacccata ttaccagcca taactggagc accattttta gcctgctggg cccgaaaaaa 360
tttctggaac tgctggtgaa caacaaaggc tttgtgagca aagtgaacgg cgaaagcgtg 420
cagatttttg gcgatgtgaa cagccatcgc aaagcggtgg tggtgagcaa atatattacc 480
aaatttaacg tgctgtataa cagctatagc cgcgatttta gccgctttga aatgattcgc 540
ccgagcattc agaccattct gcaggatatt ctgagcttta gcggcctgaa cccgggccgc 600
agcagcaaac gctatcgcgg ctttaaaagc ctgctgagcc gcattattgc gaacgataaa 660
aaatgccgct atgatattct gtatgcgaaa tttattggca ccagcaaatg caactttgcg 720
aacgtggtga gcaacaaaac cgaaattagc caggtgattc agtttgtgct gctggtgctg 780
ggcaaactgc tgccgctgga tgcgtggggc ggcgtgagca acaagaaaat tattaaagat 840
cgcgtggtgg attttctgct gctgggcgcg aacgaaaaga ttcacatgga tgatctgttt 900
cgcggcattc gcctgaaaga ttttaaatgg ctgggccgcg cgcatcagat tagcagcaaa 960
caggattttg aactgcgcac cgcgtttctg aaaggctatc tgtggtggct gtttgaacat 1020
ctgctgaaaa acattctgcg cagcttttgg tatattaccg aaaccagcag cattgtgagc 1080
ctggaactga actattttcc gcagtatctg tggaaagaac tgtatgaaag ctgggtgagc 1140
aaatatgcga aaaacaacct ggtgaaaatg ccgagcaaaa ttcagcgcga acagctgccg 1200
tgcggcaaaa ttaaactgat tccgaaacgc agcagctttc gcgtgatttg cgtgccgatt 1260
aaacgcagcc tgaaactgct gaacaagaaa ctggaactgg ataccctgga aaaagaaaaa 1320
cgcgaatttg aacgctatcg caaagaagtg ctgagcccgg tgggccagat tctgcgcctg 1380
aaactgagca aactgcgcga tacctatgaa agctatcgcg cgagcgtgca tagcagcagc 1440
gatgtggcgg aaaaaattag cgattatcgc gatagcctgc tgacccgctt tggcgaaatt 1500
ccgaaactgt ttattctgaa atttgatatg aaagaatgct atgatcgcct gagccagccg 1560
gtgctgatga aaaaactgga agaactgttt gaaaaccagg ataacaaaac cagctattat 1620
gtgcgctatt atgcgcagct ggatgcgagc cataaactga aaaaagtgaa aaccaccatt 1680
gatacccagt atcataacct gaacattctg agcagcagcc gccatctgag caactgcaaa 1740
agcctggtgg ataaaaccaa aaccattgcg ctgcagaaag gcaacattct ggaagtgtgc 1800
cgcagccaga tttatgatgt ggtgggcagc gtgaaagatg cgcgcggcaa cctgcatctg 1860
tataaacgca aacgcggcgt gtttcagggc tttagcctga gcagcatttt ttgcgatatt 1920
ctgtatagcg cgatggtgca tgattgcttt cagtttctgt ggaaaagcaa acaggatttt 1980
ctgtttgtgc gcctggtgga tgattttctg ctggtgaccc cggatagcaa catttatgat 2040
caggtgcata acattctgag cggcaaaatt ctggaaagct atggcgcgtt tgtgaacaaa 2100
gataaaaccg tggtggtgaa ccagaccacc accaaaccga gcattgattt tgtgggcctg 2160
gaagtgaaca ccaccgatct gagcattaaa cgcaacagcg gcagcattag cctggtgacc 2220
accaactttc gcacctttaa aaccctggtg aaatatctga aaacctttta tcagctgaac 2280
ctggaaggct ttctgctgga ttgcagcttt ggcgtgctgg aaaacgtgct ggaaaacatg 2340
ggcagcctgc tgcgcctggt gctgcgcgaa tttaaaacca aatttaccag cattgtgaaa 2400
tatgatacct ttcattgcta taaatttatt aaatttctgt atgatattag caactatacc 2460
attgtgaaat atgtggaaac caacagcgat tgggatggcg cgccggaact gctgaactgc 2520
attaaacaga ttattgtgaa agaatttagc agctttgaaa gctatagcga aattgtggaa 2580
tgggtgcaga ccctgaacat ttaa 2604
<210> 5
<211> 8654
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
ttcttgaaga cgaaagggcc tcgtgatacg cctattttta taggttaatg tcatgataat 60
aatggtttct tagacgtcag gtggcacttt tcggggaaat gtgcgcggaa cccctatttg 120
tttatttttc taaatacatt caaatatgta tccgctcatg agacaataac cctgataaat 180
gcttcaataa tattgaaaaa ggaagagtat gagtattcaa catttccgtg tcgcccttat 240
tccctttttt gcggcatttt gccttcctgt ttttgctcac ccagaaacgc tggtgaaagt 300
aaaagatgct gaagatcagt tgggtgcacg agtgggttac atcgaactgg atctcaacag 360
cggtaagatc cttgagagtt ttcgccccga agaacgtttt ccaatgatga gcacttttaa 420
agttctgcta tgtggcgcgg tattatcccg tgttgacgcc gggcaagagc aactcggtcg 480
ccgcatacac tattctcaga atgacttggt tgagtactca ccagtcacag aaaagcatct 540
tacggatggc atgacagtaa gagaattatg cagtgctgcc ataaccatga gtgataacac 600
tgcggccaac ttacttctga caacgatcgg aggaccgaag gagctaaccg cttttttgca 660
caacatgggg gatcatgtaa ctcgccttga tcgttgggaa ccggagctga atgaagccat 720
accaaacgac gagcgtgaca ccacgatgcc tgcagcaatg gcaacaacgt tgcgcaaact 780
attaactggc gaactactta ctctagcttc ccggcaacaa ttaatagact ggatggaggc 840
ggataaagtt gcaggaccac ttctgcgctc ggcccttccg gctggctggt ttattgctga 900
taaatctgga gccggtgagc gtgggtctcg cggtatcatt gcagcactgg ggccagatgg 960
taagccctcc cgtatcgtag ttatctacac gacggggagt caggcaacta tggatgaacg 1020
aaatagacag atcgctgaga taggtgcctc actgattaag cattggtaac tgtcagacca 1080
agtttactca tatatacttt agattgattt aaaacttcat ttttaattta aaaggatcta 1140
ggtgaagatc ctttttgata atctcatgac caaaatccct taacgtgagt tttcgttcca 1200
ctgagcgtca gaccccgtag aaaagatcaa aggatcttct tgagatcctt tttttctgcg 1260
cgtaatctgc tgcttgcaaa caaaaaaacc accgctacca gcggtggttt gtttgccgga 1320
tcaagagcta ccaactcttt ttccgaaggt aactggcttc agcagagcgc agataccaaa 1380
tactgtcctt ctagtgtagc cgtagttagg ccaccacttc aagaactctg tagcaccgcc 1440
tacatacctc gctctgctaa tcctgttacc agtggctgct gccagtggcg ataagtcgtg 1500
tcttaccggg ttggactcaa gacgatagtt accggataag gcgcagcggt cgggctgaac 1560
ggggggttcg tgcacacagc ccagcttgga gcgaacgacc tacaccgaac tgagatacct 1620
acagcgtgag ctatgagaaa gcgccacgct tcccgaaggg agaaaggcgg acaggtatcc 1680
ggtaagcggc agggtcggaa caggagagcg cacgagggag cttccagggg gaaacgcctg 1740
gtatctttat agtcctgtcg ggtttcgcca cctctgactt gagcgtcgat ttttgtgatg 1800
ctcgtcaggg gggcggagcc tatggaaaaa cgccagcaac gcggcctttt tacggttcct 1860
ggccttttgc tggccttttg ctcacatgtt ctttcctgcg ttatcccctg attctgtgga 1920
taaccgtatt accgcctttg agtgagctga taccgctcgc cgcagccgaa cgaccgagcg 1980
cagcgagtca gtgagcgagg aagcggaaga gcgcctgatg cggtattttc tccttacgca 2040
tctgtgcggt atttcacacc gcatatatgg tgcactctca gtacaatctg ctctgatgcc 2100
gcatagttaa gccagtatac actccgctat cgctacgtga ctgggtcatg gctgcgcccc 2160
gacacccgcc aacacccgct gacgcgccct gacgggcttg tctgctcccg gcatccgctt 2220
acagacaagc tgtgaccgtc tccgggagct gcatgtgtca gaggttttca ccgtcatcac 2280
cgaaacgcgc gaggcagctg cggtaaagct catcagcgtg gtcgtgaagc gattcacaga 2340
tgtctgcctg ttcatccgcg tccagctcgt tgagtttctc cagaagcgtt aatgtctggc 2400
ttctgataaa gcgggccatg ttaagggcgg ttttttcctg tttggtcact gatgcctccg 2460
tgtaaggggg atttctgttc atgggggtaa tgataccgat gaaacgagag aggatgctca 2520
cgatacgggt tactgatgat gaacatgccc ggttactgga acgttgtgag ggtaaacaac 2580
tggcggtatg gatgcggcgg gaccagagaa aaatcactca gggtcaatgc cagcgcttcg 2640
ttaatacaga tgtaggtgtt ccacagggta gccagcagca tcctgcgatg cagatccgga 2700
acataatggt gcagggcgct gacttccgcg tttccagact ttacgaaaca cggaaaccga 2760
agaccattca tgttgttgct caggtcgcag acgttttgca gcagcagtcg cttcacgttc 2820
gctcgcgtat cggtgattca ttctgctaac cagtaaggca accccgccag cctagccggg 2880
tcctcaacga caggagcacg atcatgcgca cccgtggcca ggacccaacg ctgcccgaga 2940
tgcgccgcgt gcggctgctg gagatggcgg acgcgatgga tatgttctgc caagggttgg 3000
tttgcgcatt cacagttctc cgcaagaatt gattggctcc aattcttgga gtggtgaatc 3060
cgttagcgag gtgccgccgg cttccattca ggtcgaggtg gcccggctcc atgcaccgcg 3120
acgcaacgcg gggaggcaga caaggtatag ggcggcgcct acaatccatg ccaacccgtt 3180
ccatgtgctc gccgaggcgg cataaatcgc cgtgacgatc agcggtccag tgatcgaagt 3240
taggctggta agagccgcga gcgatccttg aagctgtccc tgatggtcgt catctacctg 3300
cctggacagc atggcctgca acgcgggcat cccgatgccg ccggaagcga gaagaatcat 3360
aatggggaag gccatccagc ctcgcgtcgc gaacgccagc aagacgtagc ccagcgcgtc 3420
ggccgccatg ccggcgataa tggcctgctt ctcgccgaaa cgtttggtgg cgggaccagt 3480
gacgaaggct tgagcgaggg cgtgcaagat tccgaatacc gcaagcgaca ggccgatcat 3540
cgtcgcgctc cagcgaaagc ggtcctcgcc gaaaatgacc cagagcgctg ccggcacctg 3600
tcctacgagt tgcatgataa agaagacagt cataagtgcg gcgacgatag tcatgccccg 3660
cgcccaccgg aaggagctga ctgggttgaa ggctctcaag ggcatcggtc gagatcccgg 3720
tgcctaatga gtgagctaac ttacattaat tgcgttgcgc tcactgcccg ctttccagtc 3780
gggaaacctg tcgtgccagc tgcattaatg aatcggccaa cgcgcgggga gaggcggttt 3840
gcgtattggg cgccagggtg gtttttcttt tcaccagtga gacgggcaac agctgattgc 3900
ccttcaccgc ctggccctga gagagttgca gcaagcggtc cacgctggtt tgccccagca 3960
ggcgaaaatc ctgtttgatg gtggttaacg gcgggatata acatgagctg tcttcggtat 4020
cgtcgtatcc cactaccgag atatccgcac caacgcgcag cccggactcg gtaatggcgc 4080
gcattgcgcc cagcgccatc tgatcgttgg caaccagcat cgcagtggga acgatgccct 4140
cattcagcat ttgcatggtt tgttgaaaac cggacatggc actccagtcg ccttcccgtt 4200
ccgctatcgg ctgaatttga ttgcgagtga gatatttatg ccagccagcc agacgcagac 4260
gcgccgagac agaacttaat gggcccgcta acagcgcgat ttgctggtga cccaatgcga 4320
ccagatgctc cacgcccagt cgcgtaccgt cttcatggga gaaaataata ctgttgatgg 4380
gtgtctggtc agagacatca agaaataacg ccggaacatt agtgcaggca gcttccacag 4440
caatggcatc ctggtcatcc agcggatagt taatgatcag cccactgacg cgttgcgcga 4500
gaagattgtg caccgccgct ttacaggctt cgacgccgct tcgttctacc atcgacacca 4560
ccacgctggc acccagttga tcggcgcgag atttaatcgc cgcgacaatt tgcgacggcg 4620
cgtgcagggc cagactggag gtggcaacgc caatcagcaa cgactgtttg cccgccagtt 4680
gttgtgccac gcggttggga atgtaattca gctccgccat cgccgcttcc actttttccc 4740
gcgttttcgc agaaacgtgg ctggcctggt tcaccacgcg ggaaacggtc tgataagaga 4800
caccggcata ctctgcgaca tcgtataacg ttactggttt cacattcacc accctgaatt 4860
gactctcttc cgggcgctat catgccatac cgcgaaaggt tttgcgccat tcgatggtgt 4920
ccgggatctc gacgctctcc cttatgcgac tcctgcatta ggaagcagcc cagtagtagg 4980
ttgaggccgt tgagcaccgc cgccgcaagg aatggtgcat gcaaggagat ggcgcccaac 5040
agtcccccgg ccacggggcc tgccaccata cccacgccga aacaagcgct catgagcccg 5100
aagtggcgag cccgatcttc cccatcggtg atgtcggcga tataggcgcc agcaaccgca 5160
cctgtggcgc cggtgatgcc ggccacgatg cgtccggcgt agaggatcga gatctcgatc 5220
ccgcgaaatt aatacgactc actatagggg aattgtgagc ggataacaat tcccctctag 5280
aaataatttt gtttaacttt aagaaggaga tataccatgg gcagcagcca tcatcatcat 5340
catcacagca gcggcctggt gccgcgcggc agccatatga gcgatagcga agtgaaccag 5400
gaagcaaaac cggaagtgaa accggaagtg aaaccggaaa cccatattaa cctgaaagtg 5460
agcgatggta gcagcgaaat tttttttaaa attaaaaaaa ccaccccgct gcgccgcctg 5520
atggaagcat ttgcaaaacg ccagggtaaa gaaatggata gcctgcgctt tctgtatgat 5580
ggtattcgca ttcaggcaga tcagaccccg gaagatctgg atatggaaga taacgatatt 5640
attgaagcgc atcgcgaaca gattggcggc gaattccata tgcagaccat ctctctgctg 5700
cagtacgtta aagacaactc ttctgaccag tctgttcagc tgccgtcttt catcaactac 5760
ctgaaatctg ttaacctgat cgaaatcacc aaaccgaaca aactgccgcg tatcacctct 5820
gacacctctt accaggactt catcaacaac ctgatcaccg aactggttct gcgtaaatct 5880
cagaacgttc tggtttctgg ttacaaatct accatcgaag actctaaagt tgcgctgccg 5940
tgcgttaacc tggacggtaa cttcctgccg accaacctga acgactctaa ctggcaccgt 6000
gttttcaccc tgctgggttc tgagaagttc ctgaacctgc tgatcaacca caaaggtttc 6060
ctgaaacaca agaatggtca gcagatccag atcttcggtg acatcacctc ttacgcgaaa 6120
ccggcggcga aagcggttct gccgatcccg aaatggatct acaaattcga cgttctgtac 6180
cagtctcgta acccgcgtta ccgtaactac gaaatcatcc gtaccaacgt tcaggaagtt 6240
ctggcggaaa tcgtttctcc gtctaccaag aatccgaact ctgaaaaccc ggcggttaag 6300
aagcgtttcc gtggtatcaa gaatgttgtt tctcgtatca tctctaacga caagaagtgc 6360
cgttacgacc tgatctacaa caaatacctg tcttcttctg acacccgtaa actgaaaacc 6420
atgatcgact actctaccaa attcaaccgt gttgttgaag ttgttctgat catcatgggt 6480
aaactgctgc cgctggacgc gtggggtggt accgaaaaca agaaggttat ccaggaccgt 6540
atcgttgact tcctgcgtct gggtgcgaac gaacgtctgc acctggacga cgttctgtct 6600
ggtatcaaac tgtctaaatt caaatggctg ggtgttggta acaacatctc ttctcagcag 6660
gacttccaga tccgtaaacg tctgctggaa ggttacatca actgggtttt catctctctg 6720
gttaagaata tcgttcgtgc gttctggtac gttaccgaat cttctaacat ggaccgttct 6780
aaactgttct acttcaccca ctctatctgg aacgaactgt cttctaactg gatcaccaaa 6840
tacgcgaaag gtaacctggt tcaggttgtt tctccggaat ctaaaggtca gttcaccaac 6900
ggtaaaatca aactgatccc gaaacgtggt ggtttccgtg ttatctgcgt tccgctgaaa 6960
cagtctctgt actctttcaa caacaaacgt aacttcgcgc tgaaacagaa agagaagtgg 7020
gactacatct tctaccagaa atacaccctg tctccggttc gtcaggttct gcagctgaaa 7080
ctgaacgcgc tgcgtaaatc tgacatgggt caccgttctt ctgttaactc taccaacgaa 7140
gttgcggacc gtatcctgac cttccgtaac gacctgctga agaagaacaa aaccctgccg 7200
gttctgtaca tgatcaaatt cgacatgaaa gaatgctacg accgtctgaa ccagaacgcg 7260
ctgaaagaat ctatcgcggg tatcttcaaa gaagacaacg aaaacaccac ctaccacgtt 7320
cgtgaatacg gtaccctgga cgaatttctg aaactgaaac gtgttcgtac cctgatcgaa 7380
accgaagttc agaacttcaa catcatcatg aactctaaag acgaagcgga agcgggttct 7440
cgttcttacg gtaccaaagt tgacaaagtt aaaaccctgt ctatctctaa gaataaaatc 7500
atcgaagttt gccactctca gatcgaagac gcgacctgcc tggttaagaa taaagaaggt 7560
cagtacgacc tgttcaaacg taaacagggt gttttccagg gtttctctct gtctggtatc 7620
ttctgcgaca tcctgtactc taccatggtt tctaaagaat ttaaattcct gtgggaagcg 7680
accgaagaca acctgctgct gcgtctggtt gacgacttca tcttcatcac ctctaacaaa 7740
gacaccctga agaaggttaa agacaaaatc tcttctaacg aactgcagaa atacggtgcg 7800
ttcgttaacc acgagaagac cgttgaaatc aacggtgaag cgggttcttc taacaaaatg 7860
accttcgttg gtctggacat caactgcctg accctggacg ttaagaagga ctcttctcag 7920
ttctctcgtc cgacctgcaa attccgttct ttcaaagcgc tgttctctaa cctgaaacag 7980
ttctactgct ctaacctgtc tgaatttctg ctggacttct cttctaactc tctggaaacc 8040
atccgtgaaa acgttgacgc gatcctgaaa ctgaccttcg aagcgatcca gacctctttc 8100
gcgaccatct ctaaacagga ctctttcgaa cgttaccgtt tcatgaaatt cctgcacgtt 8160
atcatcgaaa ccaccatcga gaagttcgcg cgtgttaacg gttctatgga aggtgttgaa 8220
tacctgctga cctgcatcaa aatcaccatc accaaatctc tggcgttcat ggcgaccaaa 8280
caggaaatca tcgaatggct gtacaccctg accatcgtcg actaactcga ggatccggct 8340
gctaacaaag cccgaaagga agctgagttg gctgctgcca ccgctgagca ataactagca 8400
taaccccttg gggcctctaa acgggtcttg aggggttttt tgctgaaagg aggaactata 8460
tccggatatc ccgcaagagg cccggcagta ccggcataac caagcctatg cctacagcat 8520
ccagggtgac ggtgccgagg atgacgatga gcgcattgtt agatttcata cacggtgcct 8580
gactgcgtta gcaatttaac tgtgataaac taccgcatta aagcttatcg atgataagct 8640
gtcaaacatg agaa 8654
<210> 6
<211> 8612
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
ttcttgaaga cgaaagggcc tcgtgatacg cctattttta taggttaatg tcatgataat 60
aatggtttct tagacgtcag gtggcacttt tcggggaaat gtgcgcggaa cccctatttg 120
tttatttttc taaatacatt caaatatgta tccgctcatg agacaataac cctgataaat 180
gcttcaataa tattgaaaaa ggaagagtat gagtattcaa catttccgtg tcgcccttat 240
tccctttttt gcggcatttt gccttcctgt ttttgctcac ccagaaacgc tggtgaaagt 300
aaaagatgct gaagatcagt tgggtgcacg agtgggttac atcgaactgg atctcaacag 360
cggtaagatc cttgagagtt ttcgccccga agaacgtttt ccaatgatga gcacttttaa 420
agttctgcta tgtggcgcgg tattatcccg tgttgacgcc gggcaagagc aactcggtcg 480
ccgcatacac tattctcaga atgacttggt tgagtactca ccagtcacag aaaagcatct 540
tacggatggc atgacagtaa gagaattatg cagtgctgcc ataaccatga gtgataacac 600
tgcggccaac ttacttctga caacgatcgg aggaccgaag gagctaaccg cttttttgca 660
caacatgggg gatcatgtaa ctcgccttga tcgttgggaa ccggagctga atgaagccat 720
accaaacgac gagcgtgaca ccacgatgcc tgcagcaatg gcaacaacgt tgcgcaaact 780
attaactggc gaactactta ctctagcttc ccggcaacaa ttaatagact ggatggaggc 840
ggataaagtt gcaggaccac ttctgcgctc ggcccttccg gctggctggt ttattgctga 900
taaatctgga gccggtgagc gtgggtctcg cggtatcatt gcagcactgg ggccagatgg 960
taagccctcc cgtatcgtag ttatctacac gacggggagt caggcaacta tggatgaacg 1020
aaatagacag atcgctgaga taggtgcctc actgattaag cattggtaac tgtcagacca 1080
agtttactca tatatacttt agattgattt aaaacttcat ttttaattta aaaggatcta 1140
ggtgaagatc ctttttgata atctcatgac caaaatccct taacgtgagt tttcgttcca 1200
ctgagcgtca gaccccgtag aaaagatcaa aggatcttct tgagatcctt tttttctgcg 1260
cgtaatctgc tgcttgcaaa caaaaaaacc accgctacca gcggtggttt gtttgccgga 1320
tcaagagcta ccaactcttt ttccgaaggt aactggcttc agcagagcgc agataccaaa 1380
tactgtcctt ctagtgtagc cgtagttagg ccaccacttc aagaactctg tagcaccgcc 1440
tacatacctc gctctgctaa tcctgttacc agtggctgct gccagtggcg ataagtcgtg 1500
tcttaccggg ttggactcaa gacgatagtt accggataag gcgcagcggt cgggctgaac 1560
ggggggttcg tgcacacagc ccagcttgga gcgaacgacc tacaccgaac tgagatacct 1620
acagcgtgag ctatgagaaa gcgccacgct tcccgaaggg agaaaggcgg acaggtatcc 1680
ggtaagcggc agggtcggaa caggagagcg cacgagggag cttccagggg gaaacgcctg 1740
gtatctttat agtcctgtcg ggtttcgcca cctctgactt gagcgtcgat ttttgtgatg 1800
ctcgtcaggg gggcggagcc tatggaaaaa cgccagcaac gcggcctttt tacggttcct 1860
ggccttttgc tggccttttg ctcacatgtt ctttcctgcg ttatcccctg attctgtgga 1920
taaccgtatt accgcctttg agtgagctga taccgctcgc cgcagccgaa cgaccgagcg 1980
cagcgagtca gtgagcgagg aagcggaaga gcgcctgatg cggtattttc tccttacgca 2040
tctgtgcggt atttcacacc gcatatatgg tgcactctca gtacaatctg ctctgatgcc 2100
gcatagttaa gccagtatac actccgctat cgctacgtga ctgggtcatg gctgcgcccc 2160
gacacccgcc aacacccgct gacgcgccct gacgggcttg tctgctcccg gcatccgctt 2220
acagacaagc tgtgaccgtc tccgggagct gcatgtgtca gaggttttca ccgtcatcac 2280
cgaaacgcgc gaggcagctg cggtaaagct catcagcgtg gtcgtgaagc gattcacaga 2340
tgtctgcctg ttcatccgcg tccagctcgt tgagtttctc cagaagcgtt aatgtctggc 2400
ttctgataaa gcgggccatg ttaagggcgg ttttttcctg tttggtcact gatgcctccg 2460
tgtaaggggg atttctgttc atgggggtaa tgataccgat gaaacgagag aggatgctca 2520
cgatacgggt tactgatgat gaacatgccc ggttactgga acgttgtgag ggtaaacaac 2580
tggcggtatg gatgcggcgg gaccagagaa aaatcactca gggtcaatgc cagcgcttcg 2640
ttaatacaga tgtaggtgtt ccacagggta gccagcagca tcctgcgatg cagatccgga 2700
acataatggt gcagggcgct gacttccgcg tttccagact ttacgaaaca cggaaaccga 2760
agaccattca tgttgttgct caggtcgcag acgttttgca gcagcagtcg cttcacgttc 2820
gctcgcgtat cggtgattca ttctgctaac cagtaaggca accccgccag cctagccggg 2880
tcctcaacga caggagcacg atcatgcgca cccgtggcca ggacccaacg ctgcccgaga 2940
tgcgccgcgt gcggctgctg gagatggcgg acgcgatgga tatgttctgc caagggttgg 3000
tttgcgcatt cacagttctc cgcaagaatt gattggctcc aattcttgga gtggtgaatc 3060
cgttagcgag gtgccgccgg cttccattca ggtcgaggtg gcccggctcc atgcaccgcg 3120
acgcaacgcg gggaggcaga caaggtatag ggcggcgcct acaatccatg ccaacccgtt 3180
ccatgtgctc gccgaggcgg cataaatcgc cgtgacgatc agcggtccag tgatcgaagt 3240
taggctggta agagccgcga gcgatccttg aagctgtccc tgatggtcgt catctacctg 3300
cctggacagc atggcctgca acgcgggcat cccgatgccg ccggaagcga gaagaatcat 3360
aatggggaag gccatccagc ctcgcgtcgc gaacgccagc aagacgtagc ccagcgcgtc 3420
ggccgccatg ccggcgataa tggcctgctt ctcgccgaaa cgtttggtgg cgggaccagt 3480
gacgaaggct tgagcgaggg cgtgcaagat tccgaatacc gcaagcgaca ggccgatcat 3540
cgtcgcgctc cagcgaaagc ggtcctcgcc gaaaatgacc cagagcgctg ccggcacctg 3600
tcctacgagt tgcatgataa agaagacagt cataagtgcg gcgacgatag tcatgccccg 3660
cgcccaccgg aaggagctga ctgggttgaa ggctctcaag ggcatcggtc gagatcccgg 3720
tgcctaatga gtgagctaac ttacattaat tgcgttgcgc tcactgcccg ctttccagtc 3780
gggaaacctg tcgtgccagc tgcattaatg aatcggccaa cgcgcgggga gaggcggttt 3840
gcgtattggg cgccagggtg gtttttcttt tcaccagtga gacgggcaac agctgattgc 3900
ccttcaccgc ctggccctga gagagttgca gcaagcggtc cacgctggtt tgccccagca 3960
ggcgaaaatc ctgtttgatg gtggttaacg gcgggatata acatgagctg tcttcggtat 4020
cgtcgtatcc cactaccgag atatccgcac caacgcgcag cccggactcg gtaatggcgc 4080
gcattgcgcc cagcgccatc tgatcgttgg caaccagcat cgcagtggga acgatgccct 4140
cattcagcat ttgcatggtt tgttgaaaac cggacatggc actccagtcg ccttcccgtt 4200
ccgctatcgg ctgaatttga ttgcgagtga gatatttatg ccagccagcc agacgcagac 4260
gcgccgagac agaacttaat gggcccgcta acagcgcgat ttgctggtga cccaatgcga 4320
ccagatgctc cacgcccagt cgcgtaccgt cttcatggga gaaaataata ctgttgatgg 4380
gtgtctggtc agagacatca agaaataacg ccggaacatt agtgcaggca gcttccacag 4440
caatggcatc ctggtcatcc agcggatagt taatgatcag cccactgacg cgttgcgcga 4500
gaagattgtg caccgccgct ttacaggctt cgacgccgct tcgttctacc atcgacacca 4560
ccacgctggc acccagttga tcggcgcgag atttaatcgc cgcgacaatt tgcgacggcg 4620
cgtgcagggc cagactggag gtggcaacgc caatcagcaa cgactgtttg cccgccagtt 4680
gttgtgccac gcggttggga atgtaattca gctccgccat cgccgcttcc actttttccc 4740
gcgttttcgc agaaacgtgg ctggcctggt tcaccacgcg ggaaacggtc tgataagaga 4800
caccggcata ctctgcgaca tcgtataacg ttactggttt cacattcacc accctgaatt 4860
gactctcttc cgggcgctat catgccatac cgcgaaaggt tttgcgccat tcgatggtgt 4920
ccgggatctc gacgctctcc cttatgcgac tcctgcatta ggaagcagcc cagtagtagg 4980
ttgaggccgt tgagcaccgc cgccgcaagg aatggtgcat gcaaggagat ggcgcccaac 5040
agtcccccgg ccacggggcc tgccaccata cccacgccga aacaagcgct catgagcccg 5100
aagtggcgag cccgatcttc cccatcggtg atgtcggcga tataggcgcc agcaaccgca 5160
cctgtggcgc cggtgatgcc ggccacgatg cgtccggcgt agaggatcga gatctcgatc 5220
ccgcgaaatt aatacgactc actatagggg aattgtgagc ggataacaat tcccctctag 5280
aaataatttt gtttaacttt aagaaggaga tataccatgg gcagcagcca tcatcatcat 5340
catcacagca gcggcctggt gccgcgcggc agccatatga gcgatagcga agtgaaccag 5400
gaagcaaaac cggaagtgaa accggaagtg aaaccggaaa cccatattaa cctgaaagtg 5460
agcgatggta gcagcgaaat tttttttaaa attaaaaaaa ccaccccgct gcgccgcctg 5520
atggaagcat ttgcaaaacg ccagggtaaa gaaatggata gcctgcgctt tctgtatgat 5580
ggtattcgca ttcaggcaga tcagaccccg gaagatctgg atatggaaga taacgatatt 5640
attgaagcgc atcgcgaaca gattggcggc gaattccata tgaccgtgaa agtgaacgaa 5700
aagaaaaccc tgctgcagta tgtgctggat aacaccagca acgaagtgcc gctgctgccg 5760
agcctgaaag aatatatgga aaccgtgctg gtgtataaaa gcattaaacg cccgctgccg 5820
gcgattcgcc cgcaggaaag ctttgatgaa tttatgaaag aactggtgac ccgcctggtg 5880
atggaaaaga gcaacaacgt gattgcgtat ggctataaaa ccagcgcgat ggaaagccgc 5940
agcattttta ccacctttca tagcagcggc aactttattc tgacccatat taccagccat 6000
aactggagca ccatttttag cctgctgggc ccgaaaaaat ttctggaact gctggtgaac 6060
aacaaaggct ttgtgagcaa agtgaacggc gaaagcgtgc agatttttgg cgatgtgaac 6120
agccatcgca aagcggtggt ggtgagcaaa tatattacca aatttaacgt gctgtataac 6180
agctatagcc gcgattttag ccgctttgaa atgattcgcc cgagcattca gaccattctg 6240
caggatattc tgagctttag cggcctgaac ccgggccgca gcagcaaacg ctatcgcggc 6300
tttaaaagcc tgctgagccg cattattgcg aacgataaaa aatgccgcta tgatattctg 6360
tatgcgaaat ttattggcac cagcaaatgc aactttgcga acgtggtgag caacaaaacc 6420
gaaattagcc aggtgattca gtttgtgctg ctggtgctgg gcaaactgct gccgctggat 6480
gcgtggggcg gcgtgagcaa caagaaaatt attaaagatc gcgtggtgga ttttctgctg 6540
ctgggcgcga acgaaaagat tcacatggat gatctgtttc gcggcattcg cctgaaagat 6600
tttaaatggc tgggccgcgc gcatcagatt agcagcaaac aggattttga actgcgcacc 6660
gcgtttctga aaggctatct gtggtggctg tttgaacatc tgctgaaaaa cattctgcgc 6720
agcttttggt atattaccga aaccagcagc attgtgagcc tggaactgaa ctattttccg 6780
cagtatctgt ggaaagaact gtatgaaagc tgggtgagca aatatgcgaa aaacaacctg 6840
gtgaaaatgc cgagcaaaat tcagcgcgaa cagctgccgt gcggcaaaat taaactgatt 6900
ccgaaacgca gcagctttcg cgtgatttgc gtgccgatta aacgcagcct gaaactgctg 6960
aacaagaaac tggaactgga taccctggaa aaagaaaaac gcgaatttga acgctatcgc 7020
aaagaagtgc tgagcccggt gggccagatt ctgcgcctga aactgagcaa actgcgcgat 7080
acctatgaaa gctatcgcgc gagcgtgcat agcagcagcg atgtggcgga aaaaattagc 7140
gattatcgcg atagcctgct gacccgcttt ggcgaaattc cgaaactgtt tattctgaaa 7200
tttgatatga aagaatgcta tgatcgcctg agccagccgg tgctgatgaa aaaactggaa 7260
gaactgtttg aaaaccagga taacaaaacc agctattatg tgcgctatta tgcgcagctg 7320
gatgcgagcc ataaactgaa aaaagtgaaa accaccattg atacccagta tcataacctg 7380
aacattctga gcagcagccg ccatctgagc aactgcaaaa gcctggtgga taaaaccaaa 7440
accattgcgc tgcagaaagg caacattctg gaagtgtgcc gcagccagat ttatgatgtg 7500
gtgggcagcg tgaaagatgc gcgcggcaac ctgcatctgt ataaacgcaa acgcggcgtg 7560
tttcagggct ttagcctgag cagcattttt tgcgatattc tgtatagcgc gatggtgcat 7620
gattgctttc agtttctgtg gaaaagcaaa caggattttc tgtttgtgcg cctggtggat 7680
gattttctgc tggtgacccc ggatagcaac atttatgatc aggtgcataa cattctgagc 7740
ggcaaaattc tggaaagcta tggcgcgttt gtgaacaaag ataaaaccgt ggtggtgaac 7800
cagaccacca ccaaaccgag cattgatttt gtgggcctgg aagtgaacac caccgatctg 7860
agcattaaac gcaacagcgg cagcattagc ctggtgacca ccaactttcg cacctttaaa 7920
accctggtga aatatctgaa aaccttttat cagctgaacc tggaaggctt tctgctggat 7980
tgcagctttg gcgtgctgga aaacgtgctg gaaaacatgg gcagcctgct gcgcctggtg 8040
ctgcgcgaat ttaaaaccaa atttaccagc attgtgaaat atgatacctt tcattgctat 8100
aaatttatta aatttctgta tgatattagc aactatacca ttgtgaaata tgtggaaacc 8160
aacagcgatt gggatggcgc gccggaactg ctgaactgca ttaaacagat tattgtgaaa 8220
gaatttagca gctttgaaag ctatagcgaa attgtggaat gggtgcagac cctgaacatt 8280
taactcgagg atccggctgc taacaaagcc cgaaaggaag ctgagttggc tgctgccacc 8340
gctgagcaat aactagcata accccttggg gcctctaaac gggtcttgag gggttttttg 8400
ctgaaaggag gaactatatc cggatatccc gcaagaggcc cggcagtacc ggcataacca 8460
agcctatgcc tacagcatcc agggtgacgg tgccgaggat gacgatgagc gcattgttag 8520
atttcataca cggtgcctga ctgcgttagc aatttaactg tgataaacta ccgcattaaa 8580
gcttatcgat gataagctgt caaacatgag aa 8612
<210> 7
<211> 42
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
taggaattcc atatgcagac catctctctg ctgcagtacg tt 42
<210> 8
<211> 44
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
tcgctcgagt tagtcgacga tggtcagggt gtacagccat tcga 44
<210> 9
<211> 53
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 9
taggaattcc atatgaccgt gaaagtgaac gaaaagaaaa ccctgctgca gta 53
<210> 10
<211> 51
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 10
tcgctcgagt tagtcgacta tattcaatgt ttgtacccac tcgactattt c 51
<210> 11
<211> 12
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 11
ttagtgtaag ga 12

Claims (11)

1. Genes expressing telomerase, the genes comprising a first gene or a second gene, the first gene expressing a first telomerase; the second gene expresses a second telomerase; the amino acid sequence of the first telomerase is shown in SEQ ID NO. 1; the amino acid sequence of the second telomerase is shown in SEQ ID NO. 2.
2. The gene of claim 1, wherein the nucleotide sequence of the first gene is shown as SEQ ID No. 3; the nucleotide sequence of the second gene is shown as SEQ ID NO. 4.
3. A recombinant plasmid comprising the gene of claim 1 or 2, said recombinant plasmid being constructed with a backbone plasmid comprising pET15b-s μmo.
4. The recombinant plasmid according to claim 3, wherein the backbone plasmid for construction of the recombinant plasmid comprises pET15b-s μmo, pPICZA, pPICZaA or pTrix.
5. A recombinant cell comprising the recombinant plasmid of claim 3 or 4.
6. The recombinant cell according to claim 5, wherein when the backbone plasmid for construction of the recombinant plasmid is pET15b-s μmo, the original cell of the recombinant cell comprises Escherichia coli; when the skeleton plasmid for constructing the recombinant plasmid is pPICZA or pPICZaA, the primary cell of the recombinant cell comprises yeast; when the backbone plasmid for construction of the recombinant plasmid is pTrix, the original cells of the recombinant cells include Sf9 cells.
7. Use of the gene of claim 1 or 2 or the recombinant plasmid of claim 3 or 4 or the recombinant cell of claim 5 or 6 for the preparation of telomerase.
8. The use according to claim 7, wherein, when the original cell of the recombinant cell is E.coli, the use comprises the following steps:
1) sequentially carrying out activation culture and amplification culture on the recombinant cells to obtain a bacterial liquid; OD of the bacterial liquid600The value is 0.5 to 0.7; the culture mediums of the activation culture and the amplification culture respectively comprise LB liquid culture mediums containing ampicillin; the concentration of the ampicillin in the LB liquid culture medium is 80-120 mug/mL;
2) adding isopropyl thiogalactoside into the bacterial liquid until the molar concentration of the isopropyl thiogalactoside is 0.2-0.4 mM, and inducing telomerase to express for 12-18 h under the conditions of 100-200 rpm and 15-20 ℃ to obtain an inducing liquid;
3) centrifuging the inducing solution, and collecting the precipitate; dissolving the precipitate by using an imidazole aqueous solution to obtain a dissolved solution; the ratio of the volume of the imidazole aqueous solution to the mass of the precipitate is 8-12 mL: 1g of a compound;
4) crushing the dissolved solution under high pressure under the condition of 800-1200 bar, and then performing ultrasonic crushing under the condition of 300-500W to obtain a crushed solution;
5) centrifuging the crushed solution for 30-50 min at 10000-15000 rpm, collecting supernatant, filtering the supernatant by adopting a 0.45-micrometer filter membrane, and collecting first filtrate; and (3) loading the first filtrate to an NI chromatographic column, eluting effluent liquid by eluent, and collecting components corresponding to a third peak to obtain a crude extract containing telomerase.
9. The application of claim 8, wherein the high-pressure crushing time in the step 4) is 3-5 times, and the interval time between two adjacent high-pressure crushing times is 2-5 min; the ultrasonic crushing times are 2-4 times, the ultrasonic treatment time is 6-8 seconds, the interval is 2-4 seconds, and the ultrasonic treatment time is 2-4 min each time.
10. The use according to claim 8, wherein the loading rate in step 5) is 1 ml/min; the elution rate was 2 ml/min.
11. The use according to claim 8, wherein after the crude extract is obtained in step 5), further comprising purifying the crude extract, comprising the steps of:
6) mixing the crude extract with s mu mo enzyme, carrying out s mu mo enzyme digestion to obtain a first protein, adjusting the salt concentration of the first protein to 280mM, filtering by using a 0.45 mu m filter head, and collecting a second filtrate;
7) loading the second filtrate into an SP chromatographic column, eluting effluent liquid of eluent, collecting components corresponding to an elution peak, and performing SDS-PAGE electrophoresis, wherein the protein with the size of 100KD is a second protein;
8) reversely hanging the second protein by passing through an anti-EDTANI column at the speed of 1mL/min, and carrying out first concentration by adopting a 30KD concentration tube at the temperature of 1-5 ℃ and at the speed of 3000-4000 rpm until the volume after concentration is 0.5-1 mL to obtain a first concentrated solution;
9) loading the first concentrated solution to an S200 chromatographic column, eluting effluent liquid of eluent, collecting components corresponding to an elution peak, and performing SDS-PAGE electrophoresis, wherein the protein with the size of 100KD is a third protein;
10) and secondly concentrating the third protein by adopting a 30KD concentration tube at 1-5 ℃ and 3000-4000 rpm until the volume of the concentrated third protein is 0.5-1 mL, thus obtaining the purified telomerase.
CN202011599625.6A 2020-12-29 2020-12-29 Gene for expressing telomerase, recombinant plasmid, recombinant cell and application Pending CN112813082A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011599625.6A CN112813082A (en) 2020-12-29 2020-12-29 Gene for expressing telomerase, recombinant plasmid, recombinant cell and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011599625.6A CN112813082A (en) 2020-12-29 2020-12-29 Gene for expressing telomerase, recombinant plasmid, recombinant cell and application

Publications (1)

Publication Number Publication Date
CN112813082A true CN112813082A (en) 2021-05-18

Family

ID=75855269

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011599625.6A Pending CN112813082A (en) 2020-12-29 2020-12-29 Gene for expressing telomerase, recombinant plasmid, recombinant cell and application

Country Status (1)

Country Link
CN (1) CN112813082A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103952380A (en) * 2014-05-10 2014-07-30 浙江大学 Recombinant replication-defective adenovirus for expressing hTERT (human telomerase reverse transcriptase) gene and application thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103952380A (en) * 2014-05-10 2014-07-30 浙江大学 Recombinant replication-defective adenovirus for expressing hTERT (human telomerase reverse transcriptase) gene and application thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BUTLER,G. ET AL.: ""predicted protein [Candida tropicalis MYA-3404",Accession Number:XP_002549711.1", 《GENBANK》, pages 1 - 2 *
MUZZEY, D. ET AL.: ""Tertp [Candida albicans SC531 4]",Accession Number:XP_717626.2", 《GENBANK》, pages 1 - 2 *
周平 等: ""一组端粒相关蛋白分子的克隆"", 《世界华人消化杂志》, vol. 16, no. 14, pages 1507 - 1512 *
苗佩宏 等: ""人端粒酶反转录功能区基因的构建及其在大肠杆菌中的表达和纯化"", 《武警医学》, vol. 17, no. 2, pages 88 - 92 *

Similar Documents

Publication Publication Date Title
CN110923183A (en) Construction method of lanosterol-producing escherichia coli strain
CN110229838B (en) Method for obtaining hydroxylated compound by biotransformation of steroid compound
CN114934060A (en) Genetic engineering bacterium for producing hydroxyl tetrahydropyrimidine by utilizing tetrahydropyrimidine and construction method and application thereof
CN113980883B (en) Recombinant escherichia coli for high-yield hydroxylation steroid bulk drug and application thereof
CN112813082A (en) Gene for expressing telomerase, recombinant plasmid, recombinant cell and application
CN113073102B (en) Application of autophagy gene ATG9 in rice breeding and/or rice grain type mechanism research
CN108118047A (en) A kind of preparation method of bifunctional enzyme and its application in trehalose production
CN109957560B (en) Polypeptide with protease activity and application thereof
CN115247173A (en) Gene editing system for constructing TMPRSS6 gene mutant iron deficiency anemia pig nuclear transplantation donor cells and application thereof
CN114539425B (en) Method for improving biological expression of linear polypeptide
CN115232817A (en) Gene editing system for constructing three-gene combined mutant miniature pig nuclear transplantation donor cells and application thereof
KR100959696B1 (en) The vector for fusion protein production for analysing the antigenic epitopes of Helicobacter pylori and its method
CN115161335B (en) Gene editing system for constructing ALS model pig nuclear transfer donor cells with TARDBP gene mutation and application of gene editing system
CN111748034A (en) Preparation method of mycoplasma synoviae monoclonal antibody
CN113755512B (en) Method for preparing tandem repeat protein and application thereof
CN112553177B (en) Glutamine transaminase variant with improved heat stability
CN113234746B (en) Method for pesticide induced protein interaction and induced gene expression
CN114317473B (en) Glutamine transaminase variants with improved catalytic activity and thermostability
KR20230146330A (en) RECOMBINATION VECTOR FOR EXPRESSING NamH PROTEIN AND METHOD FOR PRODUCING NamH PROTEIN USING THE SAME
CN109666689B (en) Heterologous expression and purification method of recombinant high-temperature nickel-iron hydrogenase and application thereof
CN115232812A (en) Method for constructing nuclear transplantation donor cells of MRAP2 gene mutation severe early obesity model pigs
CN115232818A (en) Gene editing system for constructing congenital myasthenia model pig nuclear transplantation donor cells with DOK7 gene mutation and application thereof
CN115247191A (en) Gene editing system and application thereof in construction of double-gene-mutation nevus basal cell carcinoma syndrome pig nuclear transplantation donor cell
CN115232834A (en) Gene editing system for constructing nuclear transplantation donor cells of OCA-1A albinism model pigs and application thereof
CN115232793A (en) Gene editing system for constructing ALS model pig nuclear transplantation donor cells with SOD1 gene mutation and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20210518